Schizoaffective disorder

F5_SCHIZOAFF

schizoaffective disorder: A disorder in which the individual suffers from both symptoms that qualify as schizophrenia and symptoms that qualify as a mood disorder (e.g., depression or bipolar disorder) for a substantial portion (but not all) of the active period of the illness; for the remainder of the active period of the illness, the individual suffers from delusions or hallucinations in the absence of prominent mood symptoms.

Suggest a new description

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — F25 Hospital discharge: ICD-9 — 2957 Hospital discharge: ICD-8 — 2957 Cause of death: ICD-10 — F25 Cause of death: ICD-9 — 2957 Cause of death: ICD-8 — 2957 2 out of 7 registries used, show all original rules.	3223
4. Check minimum number of events None	3223
5. Include endpoints None	3223
6. Filter based on genotype QC (FinnGen only)	3223

Control definitions (FinnGen only)

Control exclude: F5_SCHIZO

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: F20-F29
Name in latin: Perturbationes schizoaffectivae

NAME	F5_SCHIZOAFF
CONTROL_EXCLUDE	F5_SCHIZO
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	F25
HD_ICD_9	2957
HD_ICD_8	2957
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	F25
COD_ICD_9	2957
COD_ICD_8	2957
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Schizoaffective disorder based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	19879	11140	8568
Only index persons	17035	9776	7259
Unadjusted period prevalence (%)
Whole population	0.28	0.32	0.24
Only index persons	0.32	0.36	0.28
Median age at first event (years)
Whole population	37.27	38.72	35.28
Only index persons	36.54	37.90	34.70

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	3223	1921	1302
Unadjusted period prevalence (%)	0.62	0.65	0.57
Median age at first event (years)	35.16	35.64	34.44

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
3082: Matched controls
30818

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

F25

ICD-10 Finland

Schizoaffective disorders

+∞

323.0

354

N05AB03

ATC

perphenazine; systemic, rectal

110.4

323.0

1122

159

F20.00

ICD-10 Finland

Paranoid schizophrenia continuous

4702.1

323.0

747

F20.30

ICD-10 Finland

Undifferentiated schizophrenia continuous

5951.2

323.0

511

N05AF05

ATC

zuclopenthixol; systemic

644.5

323.0

536

F25.0

ICD-10 Finland

Schizoaffective disorder, manic type

3844.0

323.0

353

2957A

ICD-9 Finland

Schizophrenic psychoses, Schizo-affective type

+∞

323.0

407

N06AB06

ATC

sertraline; oral

6.9

323.0

941

1845

N05AH03

ATC

olanzapine; systemic

174.9

323.0

2147

398

N03AG01

ATC

valproic acid; systemic, rectal

53.7

323.0

1633

634

N05CD07

ATC

temazepam; oral

13.3

323.0

1085

1207

P29

ICPC

Psychological sympt/compl other

12.2

323.0

787

845

F25.1

ICD-10 Finland

Schizoaffective disorder, depressive type

+∞

323.0

376

F25.00

ICD-10 Finland

Schizoaffective syndrome, manic type with only simultaneous bipolar and schizophrenic symptoms

+∞

323.0

1028

N05AX08

ATC

risperidone; systemic

97.5

323.0

1832

455

N06AB04

ATC

citalopram; systemic

6.2

323.0

1418

3722

188

Kela drug reimbursment

Psychosis requiring demanding treatment

1806.1

323.0

583

N05AH02

ATC

clozapine; systemic

1164.3

323.0

1071

F25.9

ICD-10 Finland

Schizoaffective disorder, unspecified

16384.0

323.0

1829

F31.9

ICD-10 Finland

Bipolar affective disorder, unspecified

28.8

323.0

673

296

IEY05

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, individual

22.2

323.0

487

258

F25.01

ICD-10 Finland

Schizoaffective syndrome, manic type with prolonged schizophrenic than bipolar symptoms

+∞

323.0

445

N05AX12

ATC

aripiprazole; systemic

121.1

323.0

1526

248

N03AX09

ATC

lamotrigine; oral

19.5

323.0

870

609

N05AH04

ATC

quetiapine; oral

27.0

323.0

2221

2687

F32.3

ICD-10 Finland

Severe depressive episode with psychotic symptoms

40.0

323.0

444

129

F25.20

ICD-10 Finland

Schizoaffective syndrome, mixed type with only concomitant bipolar and schizophrenic symptoms

+∞

323.0

869

P99

ICPC

Psychological disorders other

28.7

323.0

645

281

2989X

ICD-9 Finland

Other nonorganic psychoses, Unspecified psychosis

+∞

323.0

382

N05AC02

ATC

thioridazine; oral

79.0

323.0

680

110

T36

ICD-10 Finland

Poisoning by systemic antibiotics

16.1

323.0

719

571

F25.21

ICD-10 Finland

Schizoaffective syndrome, mixed type with prolonged schizophrenic than bipolar symptoms

5628.7

323.0

488

N05BA06

ATC

lorazepam; systemic, sublingual

43.2

323.0

963

321

N05BA01

ATC

diazepam; systemic, rectal

8.9

323.0

1131

1890

N04AA02

ATC

biperiden; systemic

217.1

323.0

839

N05AF03

ATC

chlorprothixene; systemic

86.7

323.0

964

161

N05AA01

ATC

chlorpromazine; systemic, rectal

239.2

323.0

614

N05AA02

ATC

levomepromazine; systemic

81.5

323.0

1277

265

F25.11

ICD-10 Finland

Schizoaffective syndrome, depressive type with prolonged schizophrenic than bipolar symptoms

+∞

323.0

447

N05AD01

ATC

haloperidol; systemic

83.2

323.0

737

116

N05BA04

ATC

oxazepam; oral

6.6

323.0

1593

4307

F29

ICD-10 Finland

Unspecified nonorganic psychosis

1839.7

323.0

1462

P72

ICPC

Schizophrenia

506.3

323.0

771

N05AN01

ATC

lithium; oral

104.0

323.0

1148

175

F25.2

ICD-10 Finland

Schizoaffective disorder, mixed type

+∞

323.0

369

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

15.5

323.0

564

439

F20.9

ICD-10 Finland

Schizophrenia, unspecified

5679.5

323.0

858

29570

ICD-8 Finland

Schizophrenia, Schizo-affective type

+∞

323.0

326

F25.10

ICD-10 Finland

Schizoaffective syndrome, depressive type with only concomitant bipolar and schizophrenic symptoms

+∞

323.0

962

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

1805.8

323.0

2954

389

ICZ03

NOMESCO Finland

Participation in compiling a psychiatric treatment plan

22.9

320.4

475

243

IGY01

NOMESCO Finland

Accelerated psychiatric treatment contact

32.7

310.7

415

146

N05AE04

ATC

ziprasidone; systemic

185.1

305.7

316

F31.20

ICD-10 Finland

Bipolar disorder, manic episode with mood-congruent psychotic symptoms

76.2

299.9

340

N05CF01

ATC

zopiclone; oral

4.4

296.7

1480

5323

IGY02

NOMESCO Finland

Psychiatric monitoring contact

25.4

284.3

407

183

F31.7

ICD-10 Finland

Bipolar affective disorder, currently in remission

25.5

278.3

398

178

F20.09

ICD-10 Finland

Paranoid schizophrenia UNS

+∞

275.2

260

F22.0

ICD-10 Finland

Delusional disorder

471.9

264.8

261

F31.6

ICD-10 Finland

Bipolar affective disorder, current episode mixed

29.9

260.6

356

134

F31.0

ICD-10 Finland

Bipolar affective disorder, current episode hypomanic

30.6

252.1

342

125

F21

ICD-10 Finland

Schizotypal disorder

1299.4

249.3

240

N05AX13

ATC

paliperidone; systemic

1264.2

242.9

234

P98

ICPC

Psychosis NOS/other

162.0

241.8

253

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

5.9

239.4

767

1649

ICB01

NOMESCO Finland

Psychiatric treatment plan, standard

17.7

235.7

381

243

P73

ICPC

Affective psychosis

124.1

234.2

251

N06AB03

ATC

fluoxetine; oral

5.3

232.0

820

1971

F20.39

ICD-10 Finland

Undifferentiated schizophrenia UNS

+∞

229.0

217

F31.30

ICD-10 Finland

Bipolar disorder Depressive episode without somatic syndrome

19.8

228.9

355

201

F25.80

ICD-10 Finland

Other specified schizoaffective disorder with only concomitant bipolar and schizophrenic symptoms

+∞

221.6

210

F20

ICD-10 Finland

Schizophrenia

+∞

219.4

208

29580

ICD-8 Finland

Schizophrenia, Other

+∞

216.2

205

ICB02

NOMESCO Finland

Psychiatric treatment plan, extended/prolonged

44.9

211.9

263

N06AX16

ATC

venlafaxine; oral

4.5

211.5

894

2564

SPAT1240

SPAT

Therapeutic discussion

4.9

210.3

792

2015

A06AD11

ATC

lactulose; oral

5.7

209.3

673

1430

IGY99

NOMESCO Finland

Other psychiatric treatment contact

21.6

205.6

309

158

IAA01

NOMESCO Finland

Assessment of need for psychiatric treatment

16.6

203.1

336

225

F60.31

ICD-10 Finland

Emotionally unstable personality disorder, borderline condition

25.6

201.5

287

123

SPAT1234

SPAT

Support of social functional capacity

12.4

200.6

378

343

F32.9

ICD-10 Finland

Depressive episode, unspecified

4.6

200.5

814

2226

N07BB01

ATC

disulfiram; oral

8.7

198.7

457

602

F60.30

ICD-10 Finland

Emotionally unstable personality disorder, impulsive

18.4

196.4

312

187

IBZ01

NOMESCO Finland

Profession-specific psychiatric evaluation

24.0

194.1

282

129

IER04

NOMESCO Finland

Rehabilitative psychiatric group intervention, functional

69.9

192.3

221

29599

ICD-8 Finland

Schizophrenia, Unspecified type

+∞

190.6

181

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

6.6

186.7

525

929

F20.5

ICD-10 Finland

Residual schizophrenia

+∞

186.4

177

IFA01

NOMESCO Finland

Psychiatric pharmacotherapy plan, not specified

25.2

186.0

266

115

N03AF01

ATC

carbamazepine; oral, rectal

8.8

181.0

413

533

F31.1

ICD-10 Finland

Bipolar affective disorder, current episode manic without psychotic symptoms

35.4

180.7

236

IGV01

NOMESCO Finland

Psychiatric network contact

80.6

180.1

203

F31.4

ICD-10 Finland

Bipolar affective disorder, current episode severe depression without psychotic symptoms

19.6

179.2

278

155

F20.0

ICD-10 Finland

Paranoid schizophrenia

+∞

177.8

169

N05AL01

ATC

sulpiride; systemic

24.4

174.6

252

112

Z76.8

ICD-10 Finland

Persons encountering health services in other specified circumstances

10.9

174.0

350

359

N05BE01

ATC

buspirone; oral

11.7

173.1

335

318

N03AE01

ATC

clonazepam; systemic

7.2

171.4

448

711

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

5.9

169.6

521

1026

F20.04

ICD-10 Finland

Paranoid schizophrenia with partial recurrence

+∞

168.3

160

SPAT1222

SPAT

Counselling/guidance promoting independent living

4.6

167.9

672

1775

2954A

ICD-9 Finland

Schizophrenic psychoses, Acute schizophrenic episode

841.8

164.2

160

F31.5

ICD-10 Finland

Bipolar affective disorder, current episode severe depression with psychotic symptoms

61.3

162.0

190

N05AE03

ATC

sertindole; oral

825.1

161.1

157

ICB03

NOMESCO Finland

Psychiatric treatment plan, monitoring

22.5

161.0

238

114

R4160

NOMESCO Finland

Other therapy enhancing rehabilitation

18.0

158.4

253

152

IFA99

NOMESCO Finland

Other psychiatric pharmacotherapy service

87.8

156.1

174

A10BA02

ATC

metformin; oral

3.3

153.8

965

3716

F20.3

ICD-10 Finland

Undifferentiated schizophrenia

786.3

153.7

150

F33.30

ICD-10 Finland

Recurrent depression, severe episode without somatic syndrome

27.8

153.5

213

29999

ICD-8 Finland

Unspecified psychosis

+∞

152.4

145

N06AX11

ATC

mirtazapine; oral

2.9

151.7

1301

6200

SPAT1254

SPAT

Administration of medicine

4.2

151.4

666

1908

F99

ICD-10 Finland

Mental disorder, not otherwise specified

14.3

150.9

265

202

P28

ICPC

Limited function/disability (P)

41.3

150.6

190

AA400

NOMESCO Finland

Electroconvulsive therapy

33.9

149.4

197

F20.34

ICD-10 Finland

Undifferentiated schizophrenia with partial recurrence

+∞

146.0

139

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

3.3

145.9

922

3543

WYA30

NOMESCO Finland

Preparations for expected poor cooperation

5.1

145.3

503

1126

F61.0

ICD-10 Finland

Mixed personality disorders

14.9

143.1

246

178

EBA00

NOMESCO Finland

Extraction of tooth

2.8

142.1

1353

6803

F25.81

ICD-10 Finland

Other specified schizoaffective disorder with prolonged schizophrenic than bipolar symptoms

+∞

141.8

135

3018D

ICD-9 Finland

Personality disorders, Other personality disorders[EPÄVAKAA PERSOONALLISUUS]

68.7

141.5

163

T90

ICPC

Diabetes non-insulin dependent

3.4

139.7

818

2955

A28

ICPC

Limited function/disability NOS

4.8

139.5

521

1262

F20.8

ICD-10 Finland

Other schizophrenia

709.3

138.9

136

N06AX03

ATC

mianserin; oral

7.5

137.2

346

514

N05AF01

ATC

flupentixol; systemic

19.7

135.6

209

113

F10.29

ICD-10 Finland

Addiction caused by alcohol UNS

11.7

134.9

259

239

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

4.1

133.6

585

1650

F60.9

ICD-10 Finland

Personality disorder, unspecified

16.5

133.4

220

143

2959E

ICD-9 Finland

Schizophrenic psychoses, Unspecified schizophrenia[ERILAISTUMATON SKITSOFRENIA,KROONINEN AKUUTTI VAIHE]

+∞

133.3

127

C07AA05

ATC

propranolol; systemic

3.1

133.1

914

3685

F10.21

ICD-10 Finland

Alcohol dependence currently abstinent, but staying in restrictive environment

29.3

131.8

180

N05AD03

ATC

melperone; systemic

33.9

131.3

173

F60.3

ICD-10 Finland

Emotionally unstable personality disorder

21.9

129.1

192

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

3.3

127.6

763

2773

X44

ICD-10 Finland

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

18.5

125.5

198

114

F31.8

ICD-10 Finland

Other bipolar affective disorders

11.2

125.3

246

237

F31

ICD-10 Finland

Bipolar affective disorder

17.7

124.9

200

120

IEY01

NOMESCO Finland

Psychoeducation, individual

38.0

124.0

159

F23.90

ICD-10 Finland

Acute and transient psychosis, unspecified without acute stress factor

+∞

121.7

116

F10.20

ICD-10 Finland

Alcohol dependence currently independent

11.4

120.0

233

219

SPAT1301

SPAT

No procedures

2.7

118.3

1122

5470

2959A

ICD-9 Finland

Schizophrenic psychoses, Unspecified schizophrenia[ERILAISTUMATON SKITSOFRENIA,TARKEMMIN MÄÄRITTELEMÄT]

+∞

116.4

111

IEV99

NOMESCO Finland

Other psychiatric network intervention

95.4

116.0

128

E950A

ICD-9 Finland

Suicide and self-inflicted poisoning by solid or liquid substances

20.0

113.5

174

F23.99

ICD-10 Finland

Acute and transient psychosis, unspecified UNS

+∞

113.2

108

F20.10

ICD-10 Finland

Raise schizophrenia continuously

+∞

113.2

108

IEY08

NOMESCO Finland

Psychiatric coaching, domestic and community skills

200.8

112.3

116

F31.2

ICD-10 Finland

Bipolar affective disorder, current episode manic with psychotic symptoms

137.4

111.9

119

SPAT1307

SPAT

Psychosocial counselling and guidance

4.6

111.1

425

1040

OAB43

SPAT

0.1

111.0

4363

IGY02

SPAT

39.6

110.2

140

SPAT1243

SPAT

Psychiatric/psychological examination

7.6

109.7

272

390

F28

ICD-10 Finland

Other nonorganic psychotic disorders

+∞

109.0

104

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

5.4

107.8

350

716

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

3.5

107.2

576

1903

IEY02

NOMESCO Finland

Intensified psychiatric outpatient care, Assertive Community Treatment (ACT)

146.5

106.9

113

2968A

ICD-9 Finland

Affective psychoses, Manic-depressive psychosis, other and unspecified

25.5

106.6

151

N05AE05

ATC

lurasidone; oral

118.3

105.7

114

103

Kela drug reimbursment

Diabetes, insulin-treated

2.8

104.8

845

3689

N06AB05

ATC

paroxetine; oral

4.6

104.4

394

948

F23.3

ICD-10 Finland

Other acute predominantly delusional psychotic disorders

+∞

103.7

IGP01

NOMESCO Finland

Psychiatric family contact

79.0

101.0

114

29530

ICD-8 Finland

Schizophrenia, Paranoid type

+∞

100.6

3018X

ICD-9 Finland

Personality disorders, Other personality disorders[MUU TAI SEKAMUOTOINEN PERSOONALLISUUSHÄIRIÖ]

34.1

99.8

131

F19.1

ICD-10 Finland

Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, harmful use

28.7

98.6

135

2959C

ICD-9 Finland

Schizophrenic psychoses, Unspecified schizophrenia[ERILAISTUMATON SKITSOFRENIA,KROONINEN]

+∞

97.4

215

Kela drug reimbursment

Diabetes, non-insulin-treated

2.7

95.6

802

3554

J18.9

ICD-10 Finland

Pneumonia, unspecified

2.8

95.4

733

3079

IER02

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, group

42.7

95.3

119

IBZ02

NOMESCO Finland

Somatic assessment of psychiatric patient

39.0

94.3

120

2988A

ICD-9 Finland

Other nonorganic psychoses, Other and unspecified reactive psychosis

+∞

93.2

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

3.9

91.4

415

1181

P50

ICPC

Psychological, Medication/prescr/renewal

46.0

90.2

111

F39

ICD-10 Finland

Unspecified mood [affective] disorder

9.9

89.0

185

197

K02.1

ICD-10 Finland

Caries of dentine

2.2

88.2

2020

14411

IER01

NOMESCO Finland

Psychoeducation, group

27.3

87.2

121

29540

ICD-8 Finland

Acute schizophrenia episode

+∞

86.9

SPAT1252

SPAT

Overall medication plan or its review

5.2

86.1

287

600

K59.09

ICD-10 Finland

Constipation, unspecified

5.5

85.3

270

532

F20.01

ICD-10 Finland

Paranoid schizophrenia periodically with gradual deterioration

+∞

84.8

IEY19

NOMESCO Finland

Psychiatric health counselling and guidance

285.5

82.0

F19.20

ICD-10 Finland

Addiction relationship caused by several drugs in combination and by other psychoactive substances currently independent

42.2

81.6

102

L17

ICPC

Foot/toe symptom/complaint

2.4

81.0

838

4110

F23.8

ICD-10 Finland

Other acute and transient psychotic disorders

+∞

80.6

RS220

NOMESCO Finland

13.3

80.5

144

113

R53

ICD-10 Finland

Malaise and fatigue

2.5

80.0

733

3366

2961E

ICD-9 Finland

Affective psychoses, Manic disorder, recurrent episode[VAKAVA MASENNUSTILA,VAIKEA-ASTEINEN+PSYKOOT PIIRTEI]

143.8

79.4

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

2.2

79.2

1051

5811

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

4.9

79.0

278

615

D12

ICPC

Constipation

7.5

78.9

195

276

K59.0

ICD-10 Finland

Constipation

5.5

78.9

247

479

F20.02

ICD-10 Finland

Paranoid schizophrenia stable periodically

+∞

78.5

N05BA12

ATC

alprazolam; oral

3.2

77.1

453

1569

ICB03

SPAT

766.9

76.6

F31.3

ICD-10 Finland

Bipolar affective disorder, current episode mild or moderate depression

16.2

76.0

125

P27

ICPC

Fear of mental disorder

12.9

75.5

137

111

N05AH05

ATC

asenapine; oral

79.5

75.5

F31.21

ICD-10 Finland

Bipolar disorder, manic episode with mood incongruent psychotic symptoms

118.8

75.2

N05BA02

ATC

chlordiazepoxide; systemic

8.3

75.2

173

219

N06AB10

ATC

escitalopram; oral

2.4

75.2

823

4127

N06AB08

ATC

fluvoxamine; oral

6.8

74.9

197

305

9691A

ICD-9 Finland

Poisoning by psychotropic agents, Phenothiazine-based tranquillisers

78.6

74.5

F19.29

ICD-10 Finland

Addiction caused by several drugs in combination and by other psychoactive substances UNS

31.9

74.5

IBA02

NOMESCO Finland

Evaluation of need for psychiatric rehabilitation

29.0

74.1

101

F30.9

ICD-10 Finland

Manic episode, unspecified

48.7

74.1

IFB01

NOMESCO Finland

Electroconvulsive Therapy (ECT)

24.3

74.1

106

F10.26

ICD-10 Finland

Alcohol dependence periodic alcoholism

9.6

74.0

156

170

30188

ICD-8 Finland

Personality disorders, Alia definita

67.1

73.8

R56.8

ICD-10 Finland

Other and unspecified convulsions

4.7

73.7

266

603

2953E

ICD-9 Finland

Schizophrenic psychoses, Paranoid type[PARANOIDISTYYPPINEN SKITSOFRENIA,KROONINEN AKUUTTI]

+∞

72.2

N06AX05

ATC

trazodone; oral

6.7

72.0

191

299

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

3.2

71.7

411

1393

N39.4

ICD-10 Finland

Other specified urinary incontinence

4.1

71.3

298

780

29510

ICD-8 Finland

Schizophrenia, Hebephrenic type

+∞

71.1

N06AX12

ATC

bupropion; oral

3.5

70.8

359

1108

ICC03

NOMESCO Finland

Psychiatric treatment plan, transfer to psychiatric ward

64.7

70.8

K04.5

ICD-10 Finland

Chronic apical periodontitis

2.2

70.3

878

4665

M01AH05

ATC

etoricoxib; oral

0.5

70.1

915

14213

F23.20

ICD-10 Finland

Acute schizophrenia-like psychosis without acute stress factor

+∞

70.1

N06AG02

ATC

moclobemide; oral

4.9

69.9

241

520

F22.9

ICD-10 Finland

Persistent delusional disorder, unspecified

355.1

69.9

Z03.2

ICD-10 Finland

Observation for suspected mental and behavioural disorders

11.7

69.7

132

117

P01

ICPC

Feeling anxious/nervous/tense

2.8

69.5

513

2058

G21.1

ICD-10 Finland

Other drug-induced secondary parkinsonism

126.3

69.2

WX290

NOMESCO Finland

Other blockade of nerve

2.0

68.6

1633

11276

S10

ICPC

Boil/carbuncle

4.3

68.5

275

692

IEZ99

NOMESCO Finland

Other psychiatric rehabilitation intervention

96.1

68.2

N06AA12

ATC

doxepin; systemic

4.6

67.8

249

574

SPAT1249

SPAT

Treatment-related counselling outside office

2.0

67.8

1304

8287

2967A

ICD-9 Finland

Affective psychoses, Bipolar affective disorder, unspecified

235.1

67.5

SPAT1217

SPAT

Assessment of need for services (elderly/care support)

5.6

66.4

205

390

R41.0

ICD-10 Finland

Disorientation, unspecified

9.6

66.1

139

151

N05CD02

ATC

nitrazepam; oral

12.3

66.0

122

103

F23.91

ICD-10 Finland

Acute and transient psychosis, unspecified without acute stress factor

651.6

65.1

F20.08

ICD-10 Finland

Paranoid schizophrenia other definite

+∞

64.8

SPAT1148

SPAT

Treatment of chronic ulcer or burn

3.0

64.7

413

1503

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

3.0

64.3

412

1504

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.9

64.2

1634

11444

U04

ICPC

Incontinence urine

5.9

64.2

189

339

F19.21

ICD-10 Finland

Addiction caused by several drugs in combination and by other psychoactive substances currently independent but staying in a controlling environment

117.6

64.1

F31.31

ICD-10 Finland

Bipolar disorder depressive episode with somatic syndrome

22.0

63.8

T82

ICPC

Obesity

4.7

63.4

229

518

SPAT1033

SPAT

Irrigation or wax removal of outer auditory canal

2.6

63.4

532

2292

P74

ICPC

Anxiety disorder/anxiety state

4.5

62.9

236

555

AA1AD

NOMESCO Finland

CT of head and brain

2.3

62.7

681

3357

SPAT1235

SPAT

Mental health, emotional support

18.5

62.2

F23.9

ICD-10 Finland

Acute and transient psychotic disorder, unspecified

620.3

62.0

110

Kela drug reimbursment

Parkinson's disease and comparable movement disrorders

9.0

61.7

134

154

29500

ICD-8 Finland

Schizophrenia, Simple type

+∞

61.7

SAA01

NOMESCO Finland

Simple examination of mouth

2.0

61.3

2303

18432

SPAT1309

SPAT

Guidance related to psychoactive substances / risk behaviour

5.4

61.2

192

372

SFA10

NOMESCO Finland

Fillning on one surface of tooth

1.9

61.0

1768

12866

F05.9

ICD-10 Finland

Delirium, unspecified

12.3

60.7

112

K08.3

ICD-10 Finland

Retained dental root

3.7

60.7

284

818

F23.29

ICD-10 Finland

Acute schizophrenia-like psychosis UNS

+∞

60.6

N06AA04

ATC

clomipramine; systemic

8.8

60.6

134

159

X78

ICD-10 Finland

Intentional self-harm by sharp object

23.5

60.4

N05AB01

ATC

dixyrazine; systemic

11.9

60.3

113

F30.20

ICD-10 Finland

Mania with mood-congruent psychotic symptoms

77.3

60.3

IBB01

NOMESCO Finland

Psychiatric functioning capacity evaluation

110.6

60.0

J01FA10

ATC

azithromycin; systemic

0.5

59.9

1039

15115

M03BX02

ATC

tizanidine; oral

0.5

59.7

1097

15713

SPAT1241

SPAT

Extensive assessment of psychosocial situation

8.6

59.4

133

161

SPAT1310

SPAT

Counselling related to known health issue

2.0

58.9

1023

6157

R60.0

ICD-10 Finland

Localized oedema

3.1

58.5

353

1233

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

3.9

58.5

261

721

S29

ICPC

Skin symptom/complaint other

2.4

58.1

550

2519

2971A

ICD-9 Finland

Paranoid states, Paranoia

+∞

57.5

F20.38

ICD-10 Finland

Undifferentiated schizophrenia other definite

+∞

57.5

N03AX11

ATC

topiramate; oral

5.7

57.3

173

320

U07.2

ICD-10 Finland

COVID-19, virus not identified

0.3

57.0

149

4318

SPAT1244

SPAT

Occupational therapy

14.7

57.0

N06AA06

ATC

trimipramine; systemic

6.0

56.8

164

287

F20.32

ICD-10 Finland

Undifferentiated schizophrenia stable periodically

+∞

56.4

A04

ICPC

Weakness/tiredness general

2.6

55.8

444

1842

IHZ07

SPAT

31.6

55.7

29899

ICD-8 Finland

Other psychoses, Reactive psychosis, unspecified

286.5

55.4

29830

ICD-8 Finland

Other psychoses, Acute paranoid reaction

+∞

55.4

IBA01

NOMESCO Finland

Diagnostic and symptom-mapping evaluation

9.7

55.2

115

123

29610

ICD-8 Finland

Affective psychoses, Manic-depression psychosis, manic type

193.5

55.1

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

2.7

55.0

416

1678

C07AB07

ATC

bisoprolol; oral

1.9

54.9

1145

7326

C03CA01

ATC

furosemide; systemic

2.3

54.6

587

2859

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

5.9

54.5

158

278

EBA05

NOMESCO Finland

Complicated extraction of tooth

2.2

54.4

688

3610

97010

ICD-8 Finland

Adverse effect of psychotherapeutics, Tranquillisers

40.9

54.3

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

3.5

54.2

269

811

SPAT1260

SPAT

Consultation of another employee

2.3

54.2

580

2817

E9509

ICD-8 Finland

Suicide and self-inflicted poisoning by solid or liquid substances, Other and unspecified solid and liquid substances

21.6

54.1

2962E

ICD-9 Finland

Affective psychoses, Major depressive disorder, single episode[PSYCH.BIPOLARIS MANICA,VAIKEA-ASTE,PSYKOOT PIIRTEIT]

190.0

54.1

F33.3

ICD-10 Finland

Recurrent depressive disorder, current episode severe with psychotic symptoms

33.0

54.0

EBA30

NOMESCO Finland

Excision of root of tooth

4.0

53.7

230

612

WX110

NOMESCO Finland

Local anesthesy

1.9

53.6

2211

17747

O80.0

ICD-10 Finland

Spontaneous vertex delivery

0.4

53.3

207

5051

F25.8

ICD-10 Finland

Other schizoaffective disorders

+∞

53.3

F61

ICD-10 Finland

Mixed and other personality disorders

17.6

53.0

F10.23

ICD-10 Finland

Alcohol dependence currently abstinent but using aversion-inducing or inhibitory medication

18.3

52.5

R1210

NOMESCO Finland

Medical assessment of need and possibilities to rehabilitation

9.2

52.2

112

126

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

2.8

52.1

372

1446

30088

ICD-8 Finland

Neuroses, Other

52.7

51.9

A46

ICD-10 Finland

Erysipelas

2.6

51.9

410

1693

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

3.1

51.8

304

1038

30041

ICD-8 Finland

Neuroses, Depressiva

13.6

51.7

IAB12

NOMESCO Finland

Psychiatric psychosis consultation

516.3

51.6

SFA30

NOMESCO Finland

Filling on tree or more surfaces of tooth

1.8

51.6

1291

8745

F20.33

ICD-10 Finland

Undifferentiated schizophrenia periodically with gradual improvement

+∞

51.2

3039X

ICD-9 Finland

Alcohol dependence syndrome, Other and unspecified alcohol dependence

10.8

51.1

100

H03AA01

ATC

levothyroxine sodium; systemic

2.1

51.1

741

4104

F60.8

ICD-10 Finland

Other specific personality disorders

13.9

51.1

IBB02

NOMESCO Finland

Psychiatric evaluation of working capacity and rehabilitation

14.1

50.9

Z71.8

ICD-10 Finland

Other specified counselling

2.0

50.8

809

4653

P80

ICPC

Personality disorder

24.5

50.7

P15

ICPC

Chronic alcohol abuse

5.1

50.7

168

346

F12.1

ICD-10 Finland

Mental and behavioural disorders due to use of cannabinoids, harmful use

22.3

50.6

N05AC01

ATC

periciazine; systemic

28.2

50.5

RS140

NOMESCO Finland

45.1

50.5

9690A

ICD-9 Finland

Poisoning by psychotropic agents, Antidepressants

45.1

50.5

V03AA01

ATC

8.1

50.5

117

150

H13

ICPC

Plugged feeling ear

2.4

50.2

502

2349

EB1AA

NOMESCO Finland

Tooth X-ray examination

1.8

49.9

1776

13405

SPAT1262

SPAT

Handing over of treatment supplies

2.3

49.9

532

2566

SPAT1221

SPAT

Guidance concerning rehabilitation services and livelihood

7.0

49.8

127

188

F10.25

ICD-10 Finland

Alcohol dependence continuous use

7.0

49.6

127

189

J44.0

ICD-10 Finland

Chronic obstructive pulmonary disease with acute lower respiratory infection

5.8

49.1

144

257

29820

ICD-8 Finland

Other psychoses, Reactive confusion

+∞

49.1

-1

NOMESCO Finland

1.8

49.0

1158

7653

9694A

ICD-9 Finland

Poisoning by psychotropic agents, Benzodiazepine-based tranquillisers

19.2

48.9

P76

ICPC

Depressive disorder

3.0

48.7

303

1076

R1220

NOMESCO Finland

Psychological examination of need and possibilities to rehabilitation

10.2

48.5

SPAT1251

SPAT

Organisation of medication

5.2

48.3

156

312

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

3.5

48.2

244

745

N06CA01

ATC

amitriptyline and psycholeptics; systemic

2.7

48.1

356

1412

SPAT1305

SPAT

Counselling and guidance related to physical exercise

2.8

47.7

330

1252

SPAT1263

SPAT

Sampling

1.8

47.7

1283

8827

G40.9

ICD-10 Finland

Epilepsy, unspecified

5.3

47.5

152

301

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

3.2

47.3

266

879

R44.3

ICD-10 Finland

Hallucinations, unspecified

48.3

47.1

F60.0

ICD-10 Finland

Paranoid personality disorder

28.4

47.0

ICZ04

NOMESCO Finland

Preparation of psychiatric treatment plan

103.7

46.9

SPAT1216

SPAT

Assessment of functional ability

2.5

46.5

398

1713

N05AX15

ATC

cariprazine; oral

101.6

45.9

S22

ICPC

Nail symptom/complaint

3.6

45.5

215

621

F10.24

ICD-10 Finland

Alcohol depence active use

7.8

45.2

107

142

F15.2

ICD-10 Finland

Mental and behavioural disorders due to use of other stimulants, including caffeine, dependence syndrome

25.7

45.1

IFA99

SPAT

74.2

45.1

N05AX16

ATC

brexpiprazole; oral

121.9

44.9

SAA02

NOMESCO Finland

Basic examination of mouth

1.7

44.8

2077

16717

IEY06

NOMESCO Finland

Psychiatric treatment and rehabilitation coaching

53.9

44.7

KMAK

NOMESCO Finland

1.7

44.4

1732

13220

B18.2

ICD-10 Finland

Chronic viral hepatitis C

7.7

44.2

105

140

W0A12

NOMESCO Finland

Planned therapy visit for psychiatric disease

14.5

44.0

E11

ICD-10 Finland

Type 2 diabetes mellitus

2.4

44.0

417

1891

F23.00

ICD-10 Finland

Acute polymorphic psychosis without actual schizophrenic disease picture without acute stress factor

+∞

43.8

29800

ICD-8 Finland

Other psychoses, Reactive depressive psychosis

+∞

43.8

2953C

ICD-9 Finland

Schizophrenic psychoses, Paranoid type[PARANOIDISTYYPPINEN SKITSOFRENIA,KROONINEN]

+∞

43.8

SFA20

NOMESCO Finland

Filling on two surfaces of tooth

1.7

43.8

1848

14411

A06AC01

ATC

ispaghula (psylla seeds); oral

2.0

43.7

675

3799

G72.8

ICD-10 Finland

Other specified myopathies

11.7

43.7

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

3.2

43.5

246

816

F30.0

ICD-10 Finland

Hypomania

29.5

43.1

IEV99

SPAT

81.3

43.0

EBA15

NOMESCO Finland

Extraction of large number of teeth

4.6

42.9

156

355

F20.03

ICD-10 Finland

Paranoid schizophrenia periodically with gradual improvement

+∞

42.8

S21

ICPC

Skin texture symptom/complaint

2.4

42.6

393

1755

P19

ICPC

Drug abuse

9.7

42.6

2961C

ICD-9 Finland

Affective psychoses, Manic disorder, recurrent episode[VAKAVA MASENNUSTILA,KESKIVAIKEA]

28.1

42.6

ICC04

NOMESCO Finland

Psychiatric treatment plan, permanent discontinuation

6.5

42.4

114

182

Z03

ICPC

Housing/neighbourhood problem

18.9

42.3

SPAT1312

SPAT

General health counselling

1.8

41.8

985

6420

H81

ICPC

Excessive ear wax

2.3

41.6

414

1921

L28

ICPC

Limited function/disability (L)

2.4

41.5

385

1721

N06AA09

ATC

amitriptyline; systemic

2.6

41.3

318

1285

F41.1

ICD-10 Finland

Generalized anxiety disorder

3.2

41.2

229

749

F41.2

ICD-10 Finland

Mixed anxiety and depressive disorder

2.5

41.2

363

1581

A29

ICPC

General symptom/complaint other

2.5

41.1

351

1504

2962C

ICD-9 Finland

Affective psychoses, Major depressive disorder, single episode[PSYCHOSIS BIPOLARIS MANICA,KESKIVAIKEA]

212.8

40.9

R25.1

ICD-10 Finland

Tremor, unspecified

5.4

40.8

127

244

2961D

ICD-9 Finland

Affective psychoses, Manic disorder, recurrent episode[VAKAVA MASENNUSTILA,VAIKEA-ASTEINEN]

27.1

40.7

30180

ICD-8 Finland

Personality disorders, Immatura

20.0

40.5

G04BD04

ATC

oxybutynin; oral, transdermal

3.8

40.4

181

500

RT250

NOMESCO Finland

35.2

40.4

J01FA09

ATC

clarithromycin; systemic

0.5

40.3

397

7030

K04.7

ICD-10 Finland

Periapical abscess without sinus

3.2

40.3

230

767

T50.9

ICD-10 Finland

Poisoning: Other and unspecified drugs, medicaments and biological substances

16.2

40.0

OAB48

SPAT

0.2

39.7

1987

F12.5

ICD-10 Finland

Mental and behavioural disorders due to use of cannabinoids, psychotic disorder

+∞

39.7

P17

ICPC

Tobacco abuse

7.6

39.6

129

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

2.3

39.4

402

1883

WZB00

NOMESCO Finland

Telephone receipt or other advice

1.8

39.2

966

6356

Z36.3

ICD-10 Finland

Antenatal screening for malformations using ultrasound and other physical methods

0.4

39.2

193

4335

R44.0

ICD-10 Finland

Auditory hallucinations

74.5

39.0

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.7

38.7

1139

7902

WVA20

SPAT

11.5

38.7

IDR03

NOMESCO Finland

Systematic group therapy, dialectical behaviour therapy (DBT)

33.9

38.5

OAA65

SPAT

0.2

38.3

2134

J69.0

ICD-10 Finland

Pneumonitis due to food and vomit

8.6

38.0

100

F40.9

ICD-10 Finland

Phobic anxiety disorder, unspecified

14.1

37.9

F44.9

ICD-10 Finland

Dissociative [conversion] disorder, unspecified

17.0

37.6

F19.25

ICD-10 Finland

Addiction caused by several drugs in combination and by other psychoactive substances continuously used

33.2

37.6

F20.20

ICD-10 Finland

Catatonic schizophrenia continuously

+∞

37.6

2956C

ICD-9 Finland

Schizophrenic psychoses, Residual schizophrenia[RESIDUAALINEN SKITSOFRENIA,KROONINEN]

+∞

37.6

30000

ICD-8 Finland

Neuroses, Anxiety neurosis

15.9

37.4

P18

ICPC

Medication abuse

13.5

37.2

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

2.8

37.1

250

929

N05AA03

ATC

promazine; systemic

70.8

37.0

F15.5

ICD-10 Finland

Mental and behavioural disorders due to use of other stimulants, including caffeine, psychotic disorder

36.7

36.9

G21.0

ICD-10 Finland

Malignant neuroleptic syndrome

131.6

36.8

Z08

ICPC

Social welfare problem

8.4

36.6

100

F40.1

ICD-10 Finland

Social phobias

4.5

36.6

135

312

F20.1

ICD-10 Finland

Hebephrenic schizophrenia

+∞

36.5

A10BH01

ATC

sitagliptin; oral

2.7

36.4

265

1031

R33

ICD-10 Finland

Retention of urine

3.4

36.3

186

573

F30.1

ICD-10 Finland

Mania without psychotic symptoms

44.6

36.0

F19.24

ICD-10 Finland

Addiction relationship caused by several drugs in combination and by other psychoactive substances active addiction

27.6

35.9

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

2.2

35.8

392

1893

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

2.3

35.8

366

1713

M01AB05

ATC

diclofenac; systemic, rectal

0.6

35.6

1277

16429

A49.9

ICD-10 Finland

Bacterial infection, unspecified

2.6

35.5

280

1141

F60.1

ICD-10 Finland

Schizoid personality disorder

28.6

35.5

E66.01

ICD-10 Finland

Obesity due to excess calories

2.5

35.5

302

1287

29560

ICD-8 Finland

Residual schizophrenia

+∞

35.5

F20.4

ICD-10 Finland

Post-schizophrenic depression

+∞

35.5

IAB01

NOMESCO Finland

Psychiatric pharmacotherapy consultation

12.8

35.3

X61

ICD-10 Finland

Intentional self-poisoning by and exposure to antiepileptic, sedative-hypnotic, antiparkinsonism and psychotropic drugs, not elsewhere classified

21.1

35.3

F15.1

ICD-10 Finland

Mental and behavioural disorders due to use of other stimulants, including caffeine, harmful use

21.1

35.3

SFC01

NOMESCO Finland

Adjuvant procedure of filling therapy

1.8

35.1

827

5331

IAB07

NOMESCO Finland

Consultation concerning a patient with self-harm intention

35.1

35.0

SPAT1292

SPAT

Other function in accordance with SHToL (Finnish classification of nursing interventions)

2.8

34.8

246

942

29699

ICD-8 Finland

Affective psychoses, Unspecified

182.0

34.8

F20.6

ICD-10 Finland

Simple schizophrenia

182.0

34.8

Z72.8

ICD-10 Finland

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

unit

cases

controls

-log₁₀(p)

N cases

N controls

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

1190

3846

4.32

307.65

2.7

1.7

1.5

1.4

13.10

1059

3463

(3028707) Methadone [Presence] in Urine by Screen method

440

568

8.81

307.65

5.2

2.8

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

1056

257

60.63

307.65

8.0

4.6

umol/l

393.0

355.5

4.01

967

224

(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma

706

123

73.22

307.65

15.6

9.4

mmol/l

0.6

1.29

656

110

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1824

8691

3.53

269.04

4.3

3.2

u/l

28.1

33.6

2.21

1722

8277

(3019309) Folate [Moles/volume] in Red Blood Cells

1027

3422

3.94

262.95

1.9

1.7

nmol/l

1212.1

1178.4

0.51

826

2652

(4198724)

193

102

20.06

248.17

4.1

3.7

—

(3013650) Neutrophils [#/volume] in Blood by Automated count

2420

14798

3.55

218.09

32.9

8.1

e9/l

4.4

4.0

19.97

2217

13019

(3015377) Calcium [Moles/volume] in Serum or Plasma

1568

7539

3.10

213.96

2.8

3.3

mmol/l

2.4

2.28

1425

6753

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

1853

9897

3.05

207.34

5.5

5.9

mmol/l

1.2

9.55

1720

9046

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

1975

10973

3.07

204.85

6.5

mmol/l

1.2

11.46

1687

9331

(3013115) Eosinophils [#/volume] in Blood

2194

13374

3.01

183.80

17.3

5.8

e9/l

0.2

14.49

1986

11911

(3018418) pH of Serum or Plasma

1359

6477

2.90

181.27

3.4

4.1

7.4

0.19

241

1271

(3006315) Basophils [#/volume] in Blood

2138

12909

2.95

181.24

13.2

5.8

e9/l

0.0

6.12

1884

11307

(3011288) Drugs identified in Urine by Screen method

440

1013

4.87

179.74

6.1

2.7

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

473

1157

4.62

179.27

4.9

2.1

—

(3001604) Monocytes [#/volume] in Blood

2129

12874

2.93

179.05

13.1

5.8

e9/l

0.6

10.26

1878

11284

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

2727

19048

3.80

176.05

7.1

7.3

u/l

76.5

75.2

0.88

2621

18040

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

162

+∞

170.33

7.9

0.0

—

(3019198) Lymphocytes [#/volume] in Blood

2156

13330

2.86

169.96

13.4

5.8

e9/l

2.1

2.0

4.22

1912

11937

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

120

23.48

165.89

2.2

2.1

umol/l

15.1

15.8

0.18

120

(3009508) Creatinine [Moles/volume] in Urine

1395

7002

2.75

164.86

3.9

3.2

mmol/l

7.0

8.1

5.25

1204

6001

(3021960) Folate [Moles/volume] in Serum or Plasma

1067

4670

2.92

163.81

1.6

1.5

nmol/l

18.3

20.7

6.77

993

4093

(3016879) Cocaine [Presence] in Urine

506

1409

4.07

160.83

4.9

2.0

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

1609

8785

2.66

159.02

2.2

1.8

pmol/l

96.6

97.1

0.15

844

4679

(40758558) Short blood count panel - Blood

1282

6314

2.71

155.26

17.9

6.3

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

662

2270

3.41

153.91

2.1

1.7

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

2796

20572

3.71

150.09

6.5

3.9

pmol/l

14.4

14.6

2.49

2666

19031

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

1425

7536

2.60

147.46

2.9

2.5

u/l

48.4

57.2

16.82

1311

7029

(3000764) Benzodiazepines [Presence] in Urine

508

1533

3.75

143.10

5.0

1.9

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

818

3315

2.97

141.95

2.1

1.8

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

636

2239

3.29

140.72

2.0

1.7

—

(3028300) Cannabinoids [Presence] in Urine

506

1548

3.69

139.48

5.1

1.9

—

(3026008) Bacteria identified in Urine by Culture

1235

6250

2.58

138.09

4.0

2.6

—

(3027008) Opiates [Presence] in Urine

503

1543

3.68

138.02

5.1

1.8

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

995

4544

2.72

137.01

1.9

1.6

pmol/l

7225208.7

34243471.5

1.69

872

3884

(3027944) Amphetamines [Presence] in Urine

490

1518

3.63

132.18

5.2

1.9

—

(42870588) Differential panel, method unspecified - Blood

1493

8382

2.46

131.95

8.9

6.0

—

(3023368) Bacteria identified in Blood by Culture

1125

5601

2.55

128.38

4.8

4.2

—

(3022096) Basophils/100 leukocytes in Blood

1858

11691

2.39

124.39

12.5

6.0

0.5

0.7

28.10

1741

10980

(3019069) Monocytes/100 leukocytes in Blood

1908

12151

2.40

124.17

13.0

6.1

8.2

8.4

1.88

1792

11468

(3044889) 12 lead EKG panel

2424

17282

2.62

121.39

5.1

3.2

—

(3024561) Albumin [Mass/volume] in Serum or Plasma

1627

9764

2.35

120.16

3.8

4.9

g/l

35.4

36.5

11.47

1515

9145

(3006504) Eosinophils/100 leukocytes in Blood

1887

12073

2.36

119.81

12.5

5.9

2.2

2.8

33.14

1767

11313

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

1915

12380

2.35

117.94

4.6

6.1

umol/l

8.3

11.0

15.84

1784

11757

(3002032) Base excess in Venous blood by calculation

514

1785

3.24

114.77

2.9

3.7

mmol/l

2.5

1.9

1.90

413

1453

(3021447) Carbon dioxide [Partial pressure] in Venous blood

516

1799

3.22

114.45

2.9

3.6

kpa

6.0

5.9

2.59

487

1749

(3013826) Glucose [Moles/volume] in Serum or Plasma

2076

13995

2.36

114.38

5.9

4.6

mmol/l

6.8

6.6

5.07

1923

12996

(3002030) Lymphocytes/100 leukocytes in Blood

1925

12603

2.31

113.16

12.6

5.9

28.7

29.1

1.03

1804

11855

(3018010) Neutrophils/100 leukocytes in Blood

1902

12430

2.29

111.72

12.6

5.7

57.7

56.4

4.85

1780

11721

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

1660

10275

2.27

110.98

2.6

2.2

nmol/l

68.0

75.2

24.42

1551

9496

(3019150) Specific gravity of Urine by Refractometry

1037

5333

2.39

106.64

5.8

3.5

kg/l

1.0

0.68

165

756

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

1211

6717

2.29

103.83

3.0

2.1

u/l

349.4

226.4

2.27

1130

6362

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

2970

24272

3.85

102.63

8.6

4.5

mu/l

1.9

2.1

0.79

2870

22687

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

2543

19254

2.52

99.90

5.3

2.9

u/l

44.0

0.00

2431

18300

(3021387) Prolactin [Units/volume] in Serum or Plasma

388

1250

3.39

97.16

2.3

1.6

mu/l

668.4

269.1

18.81

341

1132

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

388

1259

3.37

96.01

1.7

1.4

—

(3024354) Oxygen [Partial pressure] in Venous blood

420

1460

3.16

92.61

2.8

2.9

kpa

4.7

0.21

393

1414

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

3007

25136

3.93

92.31

7.2

3.8

mmol/l

6.3

5.8

51.64

2889

23358

(3008152) Bicarbonate [Moles/volume] in Arterial blood

377

1259

3.26

88.75

7.3

7.7

mmol/l

26.0

24.4

7.64

354

1171

(3031040) Bacteria [#/volume] in Urine by Automated count

2211

16139

2.18

88.70

6.2

3.9

e6/l

498.7

1838.7

1.55

188

(3019550) Sodium [Moles/volume] in Serum or Plasma

3094

26519

5.17

88.19

23.8

12.5

mmol/l

139.6

139.7

1.73

3062

25842

(3023103) Potassium [Moles/volume] in Serum or Plasma

3094

26632

5.04

85.10

23.6

12.6

mmol/l

4.0

3.9

10.67

3061

25899

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

2862

23519

2.94

84.91

7.9

4.8

mmol/mol

39.7

38.7

5.57

2739

22182

(3003396) Base excess in Arterial blood by calculation

548

2322

2.64

83.20

6.8

8.2

mmol/l

2.6

1.0

12.97

426

1805

(3020682) Albumin/Creatinine [Ratio] in Urine

1110

6450

2.10

80.13

3.9

4.0

mg/mmol

8.2

9.1

0.14

694

4142

(3027801) Oxygen [Partial pressure] in Arterial blood

541

2326

2.59

79.47

6.7

8.2

kpa

10.7

13.0

20.11

518

2233

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

541

2326

2.59

79.47

6.7

8.2

kpa

5.6

5.1

13.77

519

2231

(3021589) Normoblasts [#/volume] in Blood

1690

11498

1.99

77.73

15.1

8.7

e9/l

0.0

0.19

1384

9479

(21494755) Public health laboratory ask at order entry panel

3942

0.10

75.96

1.2

1.3

—

(3016502) Oxygen saturation in Arterial blood

492

2064

2.63

75.76

6.8

8.8

93.7

96.0

7.90

475

1993

(3002173) Hemoglobin [Mass/volume] in Arterial blood

469

1945

2.65

73.80

7.0

9.2

g/l

125.5

124.1

0.79

451

1878

(3012516) Albumin [Mass/volume] in Urine

1055

6166

2.06

73.76

3.2

3.3

mg/l

493.5

376.6

0.28

671

3925

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

1100

6529

2.04

73.68

1.8

1.6

mmol/l

1.8

1.4

21.00

992

5596

(3019060) Gas panel - Arterial blood

359

1296

2.99

73.44

5.2

5.6

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

9.11

71.56

2.6

2.1

umol/l

180.4

182.3

0.01

(3023511) Choriogonadotropin [Units/volume] in Urine

248

726

3.62

71.44

1.8

1.2

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

213

564

3.97

70.93

1.4

—

(3015736) pH of Urine

1445

9625

1.91

67.59

4.8

3.0

—

5.6

—

(3026782) Osmolality of Urine

794

4332

2.11

65.60

2.9

2.6

mosm/kgh2o

472.4

551.5

16.28

664

3683

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

717

3792

2.15

64.09

2.5

2.9

mmol/l

2.5

2.4

4.38

612

3338

(3027273) Bicarbonate [Moles/volume] in Venous blood

263

871

3.20

62.15

3.1

3.3

mmol/l

25.7

25.2

1.02

255

844

(3037467) Urinalysis macro (dipstick) panel - Urine

2233

17371

1.93

62.12

5.4

3.9

—

(3004119) Hemoglobin [Mass/volume] in Venous blood

318

1179

2.88

61.63

2.8

3.1

g/l

130.7

132.0

0.46

309

1152

(3008295) Osmolality of Serum or Plasma

122

231

5.45

61.42

1.8

1.6

mosm/kgh2o

291.0

282.6

2.37

183

(3000991) Gas panel - Venous blood

405

1707

2.57

61.06

5.2

9.1

—

(3018095) Leukocytes [#/volume] in Urine

1250

8327

1.82

55.25

4.0

3.4

e6/l

179.2

73.1

1.11

869

5699

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

162

425

3.96

54.52

2.3

1.5

—

(3014111) Lactate [Moles/volume] in Serum or Plasma

413

1857

2.40

53.84

5.2

7.4

mmol/l

1.5

1.3

1.45

395

1786

(3014576) Chloride [Moles/volume] in Serum or Plasma

525

2622

2.20

53.37

6.1

7.4

mmol/l

103.9

104.5

1.49

501

2566

(3003458) Phosphate [Moles/volume] in Serum or Plasma

549

2802

2.16

52.78

3.8

6.3

mmol/l

1.0

0.22

493

2631

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

268

983

2.88

52.77

2.6

3.8

mmol/l

24.9

24.3

1.84

221

892

(3042517) Benzodiazepines panel - Urine

15.72

52.05

2.4

2.2

—

(3012095) Magnesium [Moles/volume] in Serum or Plasma

660

3636

2.03

51.62

2.3

3.7

mmol/l

0.8

2.94

586

3435

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

286

1103

2.75

51.20

1.9

1.5

—

(3002582) Erythrocytes [#/volume] in Urine

1068

6914

1.81

50.93

3.4

3.0

e6/l

64.8

100.1

0.63

825

5222

(3011397) Hemoglobin [Presence] in Urine by Test strip

914

5641

1.87

50.88

4.5

3.2

—

(3017509) Phencyclidine [Presence] in Urine

14.71

50.23

4.2

1.2

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

225

785

3.01

48.41

6.1

6.2

2.0

1.7

2.64

213

733

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

186

5.35

48.14

1.9

1.4

—

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

905

5653

1.84

48.00

2.2

2.1

mg/l

2.9

2.8

0.70

793

4854

(3030467) Casts [#/volume] in Urine by Automated count

984

6307

1.81

47.92

3.3

2.9

e6/l

0.4

0.30

746

4668

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

3406

0.22

47.61

1.7

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

223

782

2.99

47.54

6.4

6.3

0.9

0.75

210

731

(1761868) Lipid panel - Serum or Plasma

705

11143

0.53

47.25

3.5

2.5

—

(3018405) Lactate [Moles/volume] in Arterial blood

210

717

3.06

46.90

4.0

mmol/l

1.5

1.4

0.41

203

709

(3035350) Ketones [Presence] in Urine by Test strip

1675

12531

1.70

46.54

4.9

3.2

estimate

0.0

0.80

295

2363

(3000850) Epithelial cells [#/volume] in Urine

778

4718

1.86

44.93

2.6

2.5

e6/l

9.2

6.4

4.08

680

4146

(3029937) Albumin [Presence] in Urine by Test strip

1007

6614

1.76

44.46

5.5

3.6

estimate

0.0

1.49

300

2371

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

171

5.32

44.08

3.4

2.9

—

(3020891) Body temperature

222

811

2.87

43.90

4.9

4.6

—

(3047181) Lactate [Moles/volume] in Blood

194

658

3.07

43.80

7.7

7.1

mmol/l

1.3

0.24

179

567

(3020191) Ethanol [Moles/volume] in Serum or Plasma

101

218

4.75

43.74

1.4

1.6

promille

0.7

1.4

5.42

170

(40760892) CBC W Ordered Manual Differential panel - Blood

960

6269

1.76

42.97

10.3

4.2

—

(3015235) Bicarbonate [Moles/volume] in Capillary blood

161

496

3.36

42.62

3.6

2.8

mmol/l

26.5

24.7

3.58

146

441

(3017181) Myelocytes/100 leukocytes in Blood

415

2061

2.16

42.17

7.9

4.1

1.0

0.9

0.28

141

539

(36304419) Bacteria [Presence] in Urine

956

6292

1.74

41.32

3.3

2.8

—

(3009261) Glucose [Presence] in Urine by Test strip

1664

12679

1.65

41.01

4.9

3.3

estimate

0.0

1.32

296

2337

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

230

890

2.71

40.72

2.6

2.7

0.6

0.7

0.68

215

858

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

1198

8448

1.67

39.68

4.2

3.0

ng/l

31.6

36.9

0.47

795

4851

(3021601) Nitrite [Presence] in Urine by Test strip

1638

12562

1.62

38.29

6.2

4.4

estimate

0.0

0.50

309

2438

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

260

1101

2.48

38.23

8.4

11.8

—

(3001019) Free T4 and TSH panel - Serum or Plasma

1989

0.09

38.09

1.3

1.6

—

(3043409) Potassium [Moles/volume] in Arterial blood

178

625

2.96

37.77

3.9

4.3

mmol/l

3.9

0.08

162

591

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

118

5.87

37.56

2.0

1.7

iu/ml

731020.0

1512240.9

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

2969

26876

2.33

37.49

6.2

4.2

mmol/l

2.7

2.9

40.77

2832

25286

(3002385) Erythrocyte distribution width [Ratio]

2629

22833

1.82

37.26

38.1

13.7

13.8

13.5

15.80

2590

22363

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

2961

26805

2.29

36.85

19.6

11.7

mg/l

22.9

21.4

1.70

2581

20711

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

2855

25516

2.04

36.35

4.9

3.6

mmol/l

1.7

1.3

75.17

2711

23989

(3000494) Fungus identified in Specimen by Culture

530

3033

1.89

35.85

1.4

—

(3003181) Sodium [Moles/volume] in Urine

113

310

3.74

35.67

1.4

mmol/l

50.2

64.1

3.26

259

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

148

3849

0.35

35.40

1.4

—

(3028626) Oxygen [Partial pressure] in Capillary blood

136

427

3.28

34.91

2.6

kpa

8.2

8.3

0.57

130

393

(3020564) Creatinine [Moles/volume] in Serum or Plasma

3080

28480

2.84

34.76

22.3

13.0

umol/l

74.1

73.9

0.10

3080

28469

(3002179) Metamyelocytes/100 leukocytes in Blood

370

1893

2.08

34.46

6.9

3.9

0.9

0.6

0.87

400

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

2933

26579

2.15

34.29

5.7

3.9

mmol/l

4.5

4.8

60.64

2808

25165

(3023183) Ammonium ion [Moles/volume] in Plasma

142

465

3.15

34.00

1.7

3.3

umol/l

31.2

37.4

1.65

117

416

(3013707) Erythrocyte sedimentation rate by Westergren method

2259

19008

1.63

33.83

3.6

3.9

mm/h

11.8

10.2

5.92

2091

17795

(3040151) Glucose [Moles/volume] in Capillary blood

222

4.19

33.79

23.7

5.1

mmol/l

8.6

7.1

0.52

185

(43055514) Macroprolactin [Presence] in Serum or Plasma

6.85

33.52

1.3

1.4

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

665

4173

1.75

32.93

4.0

3.3

ng/l

73.3

517.2

9.06

441

2806

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

427

2335

1.96

32.93

2.5

u/l

27.5

60.6

0.99

360

2031

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

3086

28683

2.79

32.20

13.8

9.3

u/l

28.1

27.5

0.64

3041

27879

(1616796) Gas panel - Central venous blood

141

475

3.06

32.17

3.9

3.5

—

(3021901) Oxygen saturation in Capillary blood

116

350

3.40

31.74

2.5

2.7

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

2911

26463

2.03

31.25

5.5

3.9

mmol/l

1.3

1.5

132.73

2782

24953

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

2314

0.23

31.19

1.4

—

(3039000) Anion gap in Blood

135

454

3.06

30.90

8.2

8.9

mmol/l

10.4

11.4

2.22

125

405

(3018572) Chloride [Moles/volume] in Blood

135

455

3.05

30.78

8.2

8.9

mmol/l

105.8

105.5

0.26

125

406

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

293

1448

2.13

29.76

2.5

2.3

u/l

1223.5

5561.9

4.76

588

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

606

3807

1.73

29.55

2.9

2.5

e6/l

1.6

1.1

1.65

331

2101

(3020779) Urea [Moles/volume] in Serum or Plasma

348

1847

1.99

29.09

4.1

8.7

mmol/l

8.5

8.4

0.02

329

1774

(3021440) Promyelocytes/100 leukocytes in Blood

366

1980

1.96

28.95

8.7

4.2

0.1

0.28

119

501

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

337

1773

2.01

28.87

2.1

3.4

pmol/l

4.3

4.6

4.74

284

1595

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

760

5165

1.62

27.11

2.5

2.9

ng/l

844.0

969.6

0.54

615

4273

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

262

1294

2.12

26.59

3.6

3.1

kpa

5.5

5.1

8.56

251

1204

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

121

420

2.95

26.22

1.4

1.3

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

121

420

2.95

26.22

1.4

1.3

—

(3009343) pH of Capillary blood

258

1277

2.11

26.02

3.5

3.1

7.4

0.56

167

(3007853) Bacteria identified in Skin by Aerobe culture

473

2864

1.76

26.00

1.8

1.7

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

469

2839

1.76

25.79

1.9

2.8

umol/l

5.2

7.5

3.67

332

2475

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

297

1555

2.00

25.71

3.1

3.9

ng/l

88.0

80.5

0.44

253

1390

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

330

1792

1.94

25.70

3.7

mmol/l

1.2

2.06

293

1573

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

297

1559

2.00

25.52

1.6

—

(3010421) pH of Blood

151

599

2.60

25.38

4.5

3.7

7.4

2.56

111

498

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

248

1228

2.10

24.97

3.5

3.1

mmol/l

2.9

1.5

5.45

203

921

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

208

968

2.23

24.50

2.1

1.8

—

(3025159) Blasts/100 leukocytes in Blood

337

1872

1.89

24.47

9.2

4.2

0.1

0.5

0.67

427

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

169

725

2.40

24.05

2.0

2.6

ug/l

734.1

369.3

1.11

147

677

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

552

3558

1.67

23.99

3.1

2.7

e6/l

5.5

2.6

5.18

278

1867

(40767503) Oxygen content in Capillary blood by calculation

121

448

2.77

23.30

2.8

2.5

16.4

16.7

0.32

225

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

1268

9895

1.46

23.04

5.4

3.3

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

125

480

2.67

22.44

2.6

2.3

g/l

128.0

132.2

1.12

115

344

(40761535) Cells panel - Urine sediment

324

1830

1.86

22.27

3.7

3.2

—

(3027945) Reticulocytes/100 erythrocytes in Blood

363

2131

1.79

21.98

3.7

2.7

1.8

0.30

321

1913

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

5.11

21.65

3.3

2.8

umol/l

29.2

0.01

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

168

764

2.26

20.92

2.4

2.1

ug/l

2.4

2.0

0.22

156

695

(3032080) INR in Blood by Coagulation assay

1119

8655

1.45

20.71

6.6

7.4

inr

1.1

1.2

4.27

409

2674

(3052851) Hemolysis interference index of Serum or Plasma

151

671

2.31

19.86

2.7

3.2

—

(3004809) Band form neutrophils/100 leukocytes in Blood

327

2.83

18.59

2.7

3.3

1.6

1.3

0.41

270

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

1976

0.35

18.36

1.3

1.5

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

288

1672

1.79

18.01

2.9

2.2

ug/l

4.9

7.6

2.24

245

1510

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

345

2116

1.71

17.78

2.0

2.3

g/l

0.2

0.61

308

1992

(3042936) Bacteria identified in Isolate by Culture

499

3359

1.57

17.73

1.9

2.0

—

(3024928) Oxygen saturation in Venous blood

110

447

2.51

17.65

1.7

3.0

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

257

1453

1.84

17.53

2.6

2.9

ng/l

117.5

145.0

0.67

227

1291

(3017143) Hepatitis C virus Ab [Presence] in Serum

554

3841

1.53

17.21

1.9

1.6

—

(3017732) Neutrophils [#/volume] in Blood

305

1841

1.73

16.63

10.8

2.2

e9/l

4.4

4.1

2.05

263

1529

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

6.71

16.57

1.2

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

597

4245

1.50

16.39

2.4

2.0

—

(3003740) Influenza virus B Ag [Presence] in Specimen

615

0.13

15.92

1.0

1.1

—

(3002523) Influenza virus A Ag [Presence] in Specimen

616

0.13

15.92

1.0

1.1

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

412

2727

1.59

15.63

8.7

5.8

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

130

3.73

15.57

1.0

ng/l

835.0

751.8

0.60

(3039443) Prostate specific Ag panel - Serum or Plasma

559

0.11

15.56

1.0

1.6

—

(3019977) pH of Arterial blood

4.18

15.55

6.3

2.5

7.4

0.35

(3012501) Base excess in Blood by calculation

114

504

2.31

15.23

4.8

3.9

mmol/l

3.6

2.2

2.98

334

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

28.73

15.18

1.7

1.3

nmol/l

531.4

485.7

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

375

2444

1.60

15.16

1.8

2.1

nmol/l

400.8

370.1

2.16

345

2276

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

133

3.65

15.07

1.0

ng/l

207.1

298.4

2.74

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

133

3.65

15.07

1.0

ng/l

37.6

45.2

0.28

(40768804) Tissue Pathology biopsy report

835

10592

0.71

15.04

1.9

2.0

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

350

2281

1.60

14.12

5.7

2.9

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

2702

25112

1.47

14.11

17.1

10.4

ml/min/173m2

90.3

88.2

4.39

2143

20706

(3003694) ABO and Rh group [Type] in Blood

609

8075

0.70

13.97

1.4

1.5

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

129

623

2.12

13.90

1.2

1.4

e6/l

5.2

23.4

1.91

475

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

129

623

2.12

13.90

1.2

1.5

e6/l

400.4

1458.5

1.13

105

500

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

635

4722

1.43

13.56

2.5

2.1

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

5.04

13.35

6.2

2.7

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

5.04

13.35

6.2

2.7

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

761

5863

1.39

13.21

1.9

1.8

mg/l

1.1

1.0

0.81

555

4335

(3023520) Reticulocytes [#/volume] in Blood

250

1529

1.69

12.96

2.2

2.8

e9/l

73.9

73.4

0.08

187

1137

(3013512) EKG study

807

6310

1.37

12.72

4.6

3.2

—

(3004789) Transferrin [Mass/volume] in Serum or Plasma

454

3204

1.49

12.69

1.9

2.4

g/l

2.4

0.84

406

2981

(3022948) Iron [Moles/volume] in Serum or Plasma

488

3496

1.47

12.64

2.0

2.4

umol/l

11.9

14.2

7.62

453

3254

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

115

561

2.09

12.11

1.2

1.3

—

(3026389) Candida sp identified in Specimen by Organism specific culture

344

2.39

11.92

1.7

1.3

—

(3016038) Potassium [Moles/volume] in Urine

112

3.51

11.68

1.1

mmol/l

27.2

38.0

2.43

105

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

240

2.66

11.64

1.3

1.7

—

(4034850)

153

840

1.86

11.49

18.8

8.0

—

(3045716) Anion gap in Serum or Plasma

105

3.55

11.28

2.7

mmol/l

9.7

9.9

0.08

(3022217) INR in Platelet poor plasma by Coagulation assay

355

2454

1.50

10.92

14.7

18.4

inr

1.2

0.18

377

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

181

1069

1.73

10.67

7.9

10.7

mmol/l

25.3

24.3

2.93

159

1016

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

1125

0.36

10.63

1.4

1.5

—

(3044242) Glucose [Moles/volume] in Arterial blood

3.61

10.62

4.1

1.8

—

(3007463) Buprenorphine [Presence] in Urine

10.03

10.44

2.8

6.0

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

199

2.69

10.12

2.4

3.3

60.2

55.5

0.59

138

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

1035

0.35

10.00

1.4

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

162

2.87

9.90

1.3

1.1

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

1040

0.36

9.81

1.4

—

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

130

714

1.86

9.80

1.2

1.3

mg/l

460.2

506.8

0.48

121

676

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

1039

0.36

9.79

1.4

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

1039

0.36

9.79

1.4

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

827

6716

1.31

9.68

2.3

2.0

—

(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid

138

3.00

9.57

1.2

1.4

—

67.2

—

(3022621) pH of Urine by Test strip

238

1558

1.57

9.40

5.0

2.5

—

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

219

2.54

9.37

1.2

1.4

nmol/l

1.5

1.4

0.16

202

(3043238) Trisomy 21 risk [Likelihood] in Fetus

879

0.32

9.26

1.4

1.5

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

494

1.99

9.17

1.3

1.1

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

854

0.32

9.06

1.4

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

966

0.37

8.94

1.3

1.5

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

860

0.33

8.88

1.5

1.7

—

(3050129) First trimester maternal screen panel - Serum or Plasma

1281

0.45

8.80

1.3

1.4

—

(3033658) Prothrombin time (PT) actual/Normal

764

6211

1.30

8.74

3.6

3.9

95.4

94.1

0.77

735

6057

(3000034) Microalbumin [Mass/volume] in Urine

191

2.59

8.74

3.2

3.3

mg/l

23.7

48.1

0.85

140

(3005033) Fetal Nuchal fold Thickness US

851

0.33

8.70

1.4

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

114

629

1.84

8.51

1.1

1.3

mmol/l

3.9

3.7

0.69

102

592

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

748

0.30

8.44

1.1

1.5

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

6.87

8.44

1.1

1.3

u/l

10.1

12.3

0.19

(40761511) CBC panel - Blood by Automated count

2950

28370

1.47

8.40

22.4

10.6

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

264

3754

0.68

8.37

2.3

2.6

ug/l

0.5

0.7

9.98

194

2158

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

169

1052

1.64

8.24

1.5

1.4

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

493

1.93

8.21

1.6

1.5

—

(40757373) Influenza virus identified in Isolate

4.54

8.11

1.6

1.8

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

103

561

1.86

8.03

1.2

1.7

—

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

398

2975

1.39

7.98

1.9

2.5

19.9

24.2

6.84

319

2578

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

104

3.10

7.97

1.1

1.5

pmol/l

13.2

15.3

0.90

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

339

4568

0.71

7.93

1.2

1.3

u/ml

7.1

9.9

0.44

113

1938

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

120

695

1.75

7.66

1.3

1.2

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

171

1089

1.60

7.63

2.2

2.3

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

3.17

7.53

2.6

3.3

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

289

2066

1.44

7.47

2.0

1.9

—

(4035726)

132

2101

0.61

7.08

1.4

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

4.06

7.07

1.4

1.3

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

158

1007

1.60

7.05

1.2

1.4

u/l

8.7

9.2

0.22

120

836

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

556

1.81

7.04

1.2

1.7

—

(3044290) Cell count panel - Cerebral spinal fluid

104

593

1.78

7.03

1.2

1.5

—

(3017569) Oxygen content in Arterial blood

3.10

7.00

4.8

1.9

—

(4094501)

686

0.34

6.89

1.2

1.1

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

1041

11927

0.81

6.87

3.9

—

(1761482) Bacteria [#/volume] in Urine by Culture

445

1.89

6.85

5.2

3.7

—

(44790049)

280

2.13

6.83

1.2

1.5

—

(44790047)

280

2.13

6.83

1.2

1.5

—

(44790048)

280

2.13

6.83

1.2

1.5

—

(44806118)

280

2.13

6.83

1.2

1.5

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

489

1.84

6.81

1.4

u/l

19.6

24.5

0.81

404

(3000492) Spirometry study

198

2862

0.67

6.80

1.4

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

107

626

1.73

6.64

2.8

2.9

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

358

1.98

6.64

1.2

1.5

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

416

3220

1.34

6.64

1.6

1.8

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

488

1.83

6.55

1.2

1.1

—

(3019897) Erythrocyte distribution width [Ratio] by Automated count

481

0.25

6.47

10.1

1.9

13.6

13.1

0.78

474

(3018677) aPTT in Platelet poor plasma by Coagulation assay

437

3434

1.32

6.27

1.7

2.3

29.6

29.5

0.13

416

3326

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

345

2620

1.35

6.25

2.3

2.0

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

526

1.77

6.21

2.0

2.6

ug/min

78.0

106.7

0.31

336

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

527

1.77

6.17

4.5

3.9

57.1

56.4

0.22

527

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

265

2.09

6.16

1.2

1.0

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

418

1.84

5.85

1.2

1.5

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

544

0.33

5.84

1.0

1.1

u/ml

4.8

3.7

0.15

208

(3007461) Platelets [#/volume] in Blood

3112

30479

1.61

5.77

46.9

16.6

e9/l

256.9

256.5

0.14

3079

29807

(3041918) Cholesterol [Moles/volume] in Pleural fluid

4.66

5.73

1.1

1.3

mmol/l

2.1

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

385

4852

0.77

5.62

1.2

1.3

iu/ml

17.0

27.9

4.11

1518

(3023419) Bacteria identified in Sputum by Culture

275

2.02

5.61

2.0

2.6

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

1928

20628

0.84

5.56

3.4

—

(3024731) MCV [Entitic volume]

3113

30508

1.60

5.54

46.5

16.5

90.6

90.4

1.38

3089

30176

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

753

6411

1.23

5.49

1.4

1.3

u/ml

2.0

1.6

0.22

202

1781

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

282

2119

1.36

5.48

1.2

iu/ml

81.8

154.9

3.52

817

(3026361) Erythrocytes [#/volume] in Blood

3113

30514

1.59

5.46

46.7

16.6

e12/l

4.6

1.26

3069

29784

(3002256) Pathology report gross observation

240

3223

0.72

5.43

1.2

—

(3035941) MCH [Entitic mass]

3112

30505

1.59

5.41

46.4

16.5

30.1

30.2

5.23

3088

30170

(3010813) Leukocytes [#/volume] in Blood

3113

30521

1.58

5.36

47.2

16.6

e9/l

7.3

6.6

54.51

3074

29781

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

5.57

5.32

1.4

—

(3000963) Hemoglobin [Mass/volume] in Blood

3113

30526

1.58

5.30

47.0

16.6

g/l

136.2

137.6

6.40

3090

30182

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

2.76

5.20

1.0

1.2

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

734

0.46

5.13

1.2

1.3

u/ml

3.1

7.0

—

113

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

247

0.20

5.13

1.0

1.1

—

(40761536) Microorganisms panel - Urine sediment

290

2212

1.34

5.12

4.8

3.6

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

515

1.69

5.00

1.3

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

628

0.43

4.96

1.1

u/ml

0.7

2.1

—

151

(3020491) Glucose [Moles/volume] in Blood

206

2.10

4.95

3.6

1.6

mmol/l

8.9

6.6

1.65

148

(3001122) Ferritin [Mass/volume] in Serum or Plasma

1321

11940

1.18

4.94

2.6

2.8

ug/l

104.4

108.8

0.42

1237

11243

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

112

724

1.57

4.81

1.4

2.0

iu/l

2.9

4.4

3.25

279

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

897

0.53

4.75

1.4

1.3

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

640

0.45

4.67

1.0

1.1

u/ml

0.4

1.3

1.87

271

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

453

0.35

4.62

1.2

—

(3044640) Blood type and Crossmatch panel - Blood

669

7766

0.83

4.62

2.1

2.3

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

671

0.47

4.50

1.0

1.1

u/ml

1.2

6.5

8.14

353

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

126

853

1.50

4.41

1.4

1.9

g/l

1.7

1.5

1.99

741

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

2.70

4.25

2.9

2.2

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

503

0.41

4.20

1.0

1.1

u/ml

3.7

4.3

0.12

204

(3005322) IgE [Units/volume] in Serum or Plasma

136

1922

0.69

4.19

1.3

u/ml

409.2

221.3

0.42

120

1786

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

1149

0.61

4.19

1.5

1.4

—

(3037121) Protein [Mass/volume] in Urine

115

773

1.51

4.18

2.6

3.2

g/l

0.1

0.3

1.86

334

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

499

5910

0.82

4.18

2.1

2.2

—

(3000330) Specific gravity of Urine by Test strip

148

1046

1.43

4.18

4.4

2.9

—

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

123

2.29

4.03

3.8

2.5

umol/l

54.5

48.6

0.50

104

(3037522) Nuclear Ab [Titer] in Serum

315

3906

0.79

4.00

1.2

1.4

titre

469.1

522.6

0.22

766

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

118

806

1.48

3.99

1.2

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

446

0.40

3.93

1.1

1.2

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

118

811

1.47

3.88

1.2

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

1283

0.65

3.87

1.7

1.8

mg/l

4.4

3.9

0.30

891

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

530

1.58

3.83

1.7

—

(3048689) Calprotectin [Mass/mass] in Stool

437

3647

1.23

3.79

1.6

2.5

ug/g

109.3

119.7

0.39

340

2936

(42529406) Shigella sp [Presence] in Stool by Culture

118

816

1.46

3.77

1.2

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

211

1612

1.33

3.74

1.1

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

939

0.60

3.66

1.8

1.6

iu/ml

0.0

0.3

1.21

186

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

737

0.55

3.64

1.1

u/ml

4.1

1.3

0.33

289

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

307

1.74

3.57

1.2

1.5

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

467

0.45

3.54

1.0

1.1

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

316

1.72

3.52

1.2

1.6

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

138

2.11

3.49

1.7

1.5

nmol/l

1.1

1.3

0.51

111

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

840

0.59

3.48

1.1

1.2

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

210

0.28

3.48

1.0

—

3.1

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

500

0.48

3.40

1.0

1.1

—

12.6

—

(3008898) HLA-B27 [Presence]

1219

0.66

3.36

1.1

—

(4010399)

220

1723

1.30

3.30

1.4

—

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

8.58

3.26

1.0

1.1

mmol/l

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

544

1.52

3.25

1.3

2.2

nmol/l

1.1

0.8

2.28

466

(4024509)

192

1.88

3.19

2.1

1.4

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

473

0.48

3.17

1.1

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

483

0.49

3.11

1.0

1.1

u/ml

4.4

2.7

—

258

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

673

1.46

3.11

1.6

1.7

—

(40768795) Lymph node Pathology biopsy report

247

0.36

3.03

1.3

1.2

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

491

0.51

3.02

1.2

1.3

ug/l

3.1

3.9

0.49

451

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

240

1.76

3.01

1.3

1.4

mmol/l

12.9

12.6

0.06

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

2.31

3.00

1.3

1.1

—

23.8

—

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

553

0.54

2.97

1.2

—

7.9

—

(3036180) Methadone [Presence] in Urine

6.68

2.86

1.5

1.4

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

564

6401

0.86

2.85

1.7

1.6

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

467

0.51

2.84

1.1

1.2

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

2.35

2.81

3.2

2.3

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

306

2545

1.22

2.78

1.6

1.5

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

195

1.80

2.75

1.3

1.7

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

195

1.80

2.75

1.3

1.7

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

195

1.80

2.75

1.3

1.7

—

(3026926) Nortriptyline [Moles/volume] in Serum or Plasma

8.34

2.75

1.8

2.3

nmol/l

166.4

231.2

—

(1002224) Polysomnography panel

109

1474

0.73

2.68

1.1

—

(40768800) Prostate Pathology biopsy report

336

0.44

2.66

1.2

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

1135

0.70

2.63

1.2

1.3

u/ml

0.3

1.0

1.38

102

(36660697) Celiac disease serology panel - Serum

276

2288

1.23

2.60

1.2

—

(3006653) Thiamine [Moles/volume] in Blood

141

1.92

2.60

1.5

1.4

nmol/l

146.0

134.2

0.81

141

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

211

0.38

2.53

1.1

1.2

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

150

1.87

2.51

1.0

1.1

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

394

0.50

2.49

2.4

—

(3022313) Gas panel - Capillary blood

124

936

1.34

2.49

3.4

3.1

—

(3022145) Colonoscopy Study observation

236

2860

0.81

2.49

1.2

1.3

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

883

0.67

2.42

1.4

2.0

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

528

1.43

2.31

1.9

3.6

mg/l

44.7

69.8

0.95

419

(3041096) Erythrocytes [Presence] in Urine by Automated

795

7244

1.13

2.30

4.7

2.9

—

(3023410) Appearance of Cerebral spinal fluid

292

1.58

2.30

1.3

1.7

—

(3052592) Norovirus Ag [Presence] in Stool

2.86

2.30

1.2

1.4

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

324

1.55

2.30

1.2

1.6

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

368

0.51

2.28

1.2

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

274

0.44

2.28

1.0

1.1

—

(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood

353

0.51

2.24

1.2

1.1

—

3.2

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

171

1.76

2.24

1.2

1.6

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

0.00

2.24

0.0

1.3

—

(4062490)

299

0.47

2.23

1.1

1.4

—

(3026692) Albumin [Mass/volume] in Peritoneal fluid

0.00

2.22

0.0

1.5

—

12.7

—

(3020630) Protein [Mass/volume] in Serum or Plasma

197

1606

1.24

2.21

1.8

2.7

g/l

65.2

67.0

2.50

180

1497

(44806420)

2.51

2.18

3.6

2.6

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

267

0.45

2.15

1.8

1.5

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

528

1.41

2.14

1.9

3.6

mg/l

36.6

38.6

0.10

420

(40768443) Skin Pathology biopsy report

1032

0.72

2.12

1.1

1.2

—

(3004616) Nuclear Ab [Presence] in Serum

318

0.50

2.10

1.3

1.2

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

514

1.41

2.08

1.9

3.6

ratio

1.3

2.6

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

400

1.46

2.02

1.3

1.8

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

225

1.61

1.96

3.3

3.6

—

(3005719) IgG [Mass/volume] in Serum or Plasma

171

2081

0.81

1.93

1.7

2.6

g/l

10.1

10.5

1.00

154

1905

(3048879) Bone marrow aspiration report

0.00

1.88

0.0

2.6

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

662

0.68

1.88

1.1

1.2

—

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

141

0.35

1.87

2.0

2.7

—

91.8

—

(3045142) Bone marrow Pathology biopsy report

251

0.48

1.85

1.3

1.4

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

2.40

1.85

1.0

1.2

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

199

1660

1.21

1.84

1.3

iu/l

23.0

26.0

0.65

143

1421

(3013945) Hepatitis B virus e Ab [Presence] in Serum

3.53

1.83

1.0

1.9

—

(3019225) pH of Specimen

251

2142

1.19

1.82

3.6

3.8

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

435

1.41

1.81

2.5

3.0

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

597

5426

1.12

1.80

1.8

1.7

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

631

0.68

1.79

1.2

u/ml

310.6

255.7

0.55

418

(3024980) IgG subclass 4 [Mass/volume] in Serum

475

0.63

1.79

1.0

1.7

g/l

0.4

0.8

5.62

362

(3002619) Bacteria identified in Specimen by Culture

2.35

1.77

1.3

1.1

—

(3023199) Leukocytes [#/volume] in Pleural fluid

177

1.64

1.76

1.3

1.4

e6/l

2035.5

2247.9

0.14

127

(3027974) Hepatitis B virus e Ag [Presence] in Serum

3.34

1.74

1.0

1.8

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

520

0.65

1.74

1.2

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

102

794

1.29

1.74

1.9

1.7

—

(3045414) Leukocytes [Presence] in Urine

137

1107

1.25

1.73

2.4

1.8

—

(3005082) Progesterone [Moles/volume] in Serum or Plasma

217

0.46

1.72

1.4

1.3

nmol/l

21.1

33.3

—

189

(3048929) Epstein Barr virus Ab [Presence] in Serum

1061

0.76

1.71

1.2

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

202

1.59

1.71

1.2

1.1

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

0.00

1.70

0.0

4.9

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

624

0.68

1.70

1.1

1.2

—

(3016018) Differential panel - Cerebral spinal fluid

307

1.47

1.70

1.1

1.5

—

(3005011) Chlamydia sp Ab [Titer] in Serum

0.00

1.70

0.0

1.5

—

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

179

0.45

1.68

3.1

1.8

mg/l

2.9

3.9

—

172

(3051101) Glucose [Moles/volume] in Cord blood

2.80

1.65

9.0

5.8

—

(3014051) Protein [Presence] in Urine by Test strip

547

1.34

1.64

2.9

2.0

—

(3009542) Hematocrit [Volume Fraction] of Blood

2535

25895

0.90

1.64

36.0

11.8

39.3

40.6

6.93

1534

20733

(3007566) Smooth muscle Ab [Titer] in Serum

775

1.29

1.63

1.2

1.3

titre

91.5

81.1

0.17

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

225

0.49

1.62

1.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

225

0.49

1.62

1.1

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

224

0.49

1.61

1.1

—

(40765089) Chromosome analysis panel - Blood by G-banded

134

0.37

1.60

1.0

—

(21494815) CD4 cells/100 lymphocytes in Specimen

237

0.50

1.60

2.6

2.4

—

43.8

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

223

0.49

1.59

1.1

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

223

0.49

1.59

1.1

—

(3011412) CD3 cells [#/volume] in Blood

262

0.53

1.59

2.1

2.5

e9/l

0.8

1.2

—

155

(40760888) Immunoglobulin light chains.free panel - Serum

406

1.39

1.55

1.6

3.8

—

(3006462) Nitrate [Presence] in Urine

107

1.78

1.54

2.1

3.1

—

(3003434) Protein [Mass/volume] in Pleural fluid

192

1.57

1.54

1.4

1.5

g/l

35.9

33.7

0.48

169

(3025941) Bacteria identified in Stool by Culture

193

1638

1.19

1.53

1.3

1.2

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

205

0.49

1.50

1.0

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

139

1146

1.22

1.49

1.4

1.5

—

(3009871) Measles virus Ab [Titer] in Serum

125

0.40

1.49

1.6

1.7

—

(3000093) Morphology [Interpretation] in Blood Narrative

194

1.55

1.48

1.0

1.2

—

(3045788) Cell count panel - Pleural fluid

139

1.66

1.48

1.5

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

259

1.47

1.48

1.2

1.8

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

166

0.48

1.46

1.3

1.2

—

(3023420) DNA double strand Ab [Units/volume] in Serum

305

0.59

1.46

1.3

1.6

—

26.6

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

2.73

1.43

1.0

—

(3028026) IgM [Mass/volume] in Serum or Plasma

135

1623

0.82

1.41

1.3

1.8

g/l

1.1

1.3

2.28

123

1504

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

226

0.53

1.41

1.1

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

214

1.50

1.38

1.1

—

(3011648) Oxygen content in Venous blood

182

1.54

1.37

1.2

2.3

11.2

11.3

0.04

182

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

298

0.60

1.35

1.2

—

(3032868) Hemoglobin electrophoresis panel in Blood

0.00

1.34

0.0

1.5

—

(4038314)

0.00

1.34

0.0

1.3

—

(40768797) Stomach Pathology biopsy report

307

3441

0.88

1.34

1.2

—

(4211845)

120

1.67

1.34

2.0

3.0

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

0.00

1.33

0.0

1.2

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

0.00

1.33

0.0

1.0

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

109

889

1.23

1.33

2.1

1.9

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

200

1.50

1.32

1.0

1.2

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

220

0.54

1.31

2.4

1.8

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

1173

0.80

1.31

1.6

2.1

u/l

40.5

39.4

0.16

1073

(36304617) Golimumab [Mass/volume] in Serum or Plasma by Immunoassay

0.00

1.31

0.0

1.9

—

1.5

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

201

1.50

1.29

2.6

2.4

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

101

820

1.24

1.29

3.6

3.2

mmol/l

25.3

24.8

0.72

765

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

173

0.52

1.29

1.4

1.3

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

185

1.52

1.29

2.2

2.3

—

(3020393) Adenovirus Ag [Presence] in Stool

2.78

1.28

1.0

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

175

0.51

1.28

3.8

7.0

—

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

194

1.50

1.26

1.2

1.7

ug/l

32.5

19.4

0.42

189

(3035637) Corticotropin [Mass/volume] in Plasma

294

1.40

1.26

1.3

1.6

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

203

1.48

1.24

1.0

1.2

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

2.23

1.24

1.5

1.9

ng/l

115.1

126.6

—

(3022689) Creatine [Moles/volume] in Urine

1.86

1.23

1.4

1.5

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

2.00

1.23

1.6

1.4

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

156

1.54

1.20

1.4

e6/l

10930.9

89152.2

0.97

(40768793) Breast Pathology biopsy report

580

0.74

1.19

1.3

—

(3026493) Urate [Moles/volume] in Serum or Plasma

599

6433

0.92

1.18

2.2

2.4

umol/l

2582.2

4056.7

0.54

496

5741

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

2.31

1.18

1.0

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

125

1.60

1.17

1.2

1.6

—

(3014271) Vancomycin [Susceptibility]

1.78

1.16

3.6

2.4

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

299

1.38

1.16

6.4

7.0

mg/l

10.7

10.8

0.05

275

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

0.00

1.16

0.0

1.1

—

(3014891) Appearance of Pleural fluid

2.50

1.15

1.2

1.6

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

126

1.59

1.14

1.2

1.6

—

(40768446) Kidney Pathology biopsy report

111

0.45

1.13

1.0

1.6

—

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

196

0.56

1.12

1.2

1.1

—

33.9

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

556

1.26

1.11

1.7

2.3

g/l

0.0

0.83

525

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

512

1.28

1.10

1.8

2.4

g/l

0.0

0.00

482

(3002621) Streptococcal DNAse B [Units/volume] in Serum

2.38

1.09

1.0

1.1

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

194

0.57

1.09

3.8

2.0

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

1.95

1.08

1.3

—

(3041806) Other cells [#/volume] in Blood by Manual count

164

0.55

1.08

1.8

1.6

—

(1175426) CD3 cells/100 lymphocytes in Blood

206

0.58

1.08

2.3

2.1

70.0

74.3

0.29

194

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

514

1.27

1.08

1.8

2.4

g/l

0.0

0.00

483

(3020717) Zinc [Moles/volume] in Serum or Plasma

161

1.49

1.06

1.2

1.5

umol/l

21.4

25.2

0.30

151

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

430

0.72

1.05

1.0

1.1

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

660

1.23

1.05

1.4

ug/g

316.9

296.2

0.41

356

(3037756) Immunofixation for Serum or Plasma

375

1.31

1.04

1.1

1.7

—

(3003327) Ova and parasites identified in Stool by Light microscopy

116

981

1.19

1.03

1.4

1.8

—

(40768441) Liver Pathology biopsy report

203

0.59

1.03

1.1

1.5

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

138

1.53

1.02

1.0

1.1

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

663

1.23

1.01

1.8

2.3

g/l

9.9

10.3

0.46

582

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

225

0.62

0.99

1.2

u/ml

0.0

0.5

—

(40762814) Titanium [Mass/volume] in Blood

0.00

0.97

0.0

2.2

—

3.5

—

(3035509) Tobramycin [Mass/volume] in Serum or Plasma

0.00

0.96

0.0

2.1

—

1.4

—

(3003338) MCHC [Mass/volume]

2456

24146

1.07

0.95

45.0

13.9

g/l

331.3

333.4

23.96

2443

23975

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

141

1.49

0.94

1.1

1.6

—

(3004588) Protein electrophoresis panel - Serum or Plasma

149

1301

1.15

0.92

1.7

2.3

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

727

1.20

0.91

1.8

2.0

pmol/l

168.8

210.8

2.38

686

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

691

1.21

0.90

1.8

2.3

g/l

3.2

3.1

0.51

547

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

110

1.55

0.90

1.0

1.3

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

102

0.49

0.89

1.0

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

565

1.23

0.89

1.7

2.3

g/l

37.7

38.2

0.30

505

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

584

0.78

0.88

1.2

1.4

u/ml

92.5

114.1

1.16

118

(3036489) Thrombin time

119

1026

1.17

0.88

1.6

2.2

19.6

21.0

4.63

101

882

(3028717) Thiamine [Mass/volume] in Blood

2.00

0.87

1.0

1.2

—

(3021788) Differential panel - Synovial fluid

413

0.75

0.85

1.3

1.6

—

(3035947) Staphylolysin Ab [Units/volume] in Serum

112

1.52

0.84

1.1

1.2

—

4.4

—

(3019832) Treponema pallidum Ab [Presence] in Serum

355

3837

0.92

0.84

1.8

1.7

—

(3034092) Cytoplasmic Ig cells/100 cells in Blood

1.94

0.84

18.8

3.2

—

(3037556) Urate [Mass/volume] in Serum or Plasma

1.69

0.82

1.6

1.2

—

(3036782) Glucose [Moles/volume] in Pleural fluid

155

1.42

0.81

1.1

1.4

mmol/l

6.5

6.4

0.07

143

(3029080) Hemoglobin [Entitic mass] in Reticulocytes

241

1.33

0.80

1.7

2.2

32.8

32.5

0.24

241

(3032352) Blasts [#/volume] in Cerebral spinal fluid

0.00

0.79

0.0

3.2

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

730

1.18

0.79

1.8

2.3

g/l

7.6

7.3

1.00

565

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

730

1.18

0.79

1.8

2.3

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

730

1.18

0.79

1.8

2.3

g/l

3.7

0.10

534

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

1.67

0.78

1.1

—

(3007542) Rye IgE Ab [Units/volume] in Serum

0.00

0.78

0.0

1.1

—

1.3

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

402

1.25

0.78

1.2

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

295

1.29

0.78

1.2

1.4

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

199

0.65

0.78

1.0

1.1

u/l

1.0

1.1

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

621

1.20

0.77

2.0

2.4

g/l

0.5

0.7

0.26

562

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

125

0.56

0.77

1.1

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

258

2361

1.10

0.77

2.2

4.6

u/l

220.9

239.8

1.71

233

2248

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

222

0.67

0.77

1.2

1.5

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

191

1.36

0.77

3.5

4.2

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

474

5040

0.93

0.76

1.6

1.5

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

103

1187

0.86

0.76

1.4

1.3

miu/ml

207.8

223.0

0.12

593

(3018001) Oat IgE Ab [Units/volume] in Serum

0.00

0.76

0.0

1.0

—

0.3

—

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

427

0.77

0.76

1.1

2.9

—

1753.3

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

124

1.45

0.75

1.1

1.8

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

2.08

0.74

2.6

2.3

u/field

0.8

—

(3004775) Volume in Urine collected for unspecified duration

175

1.37

0.74

2.2

2.6

828.9

606.3

1.13

125

(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay

107

0.56

0.72

1.7

1.6

163.7

153.0

—

102

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

107

0.56

0.72

1.3

1.1

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

1.52

0.72

1.0

1.3

—

(3036670) Protein [Mass/volume] in Synovial fluid

1.67

0.72

1.0

1.3

g/l

33.7

39.0

—

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

159

0.63

0.72

1.2

1.1

—

11.1

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

353

1.25

0.71

1.1

1.2

u/l

42.3

35.8

0.14

305

(4146454)

220

1.32

0.71

2.1

2.7

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

206

0.68

0.71

1.1

1.3

—

(3017704) Immunofixation for Urine

109

1.47

0.70

1.1

1.7

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

444

0.79

0.70

2.1

2.2

umol/l

4.2

5.3

1.02

318

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

619

0.82

0.70

1.2

1.4

—

(3051593) INR in Capillary blood by Coagulation assay

1.55

0.69

5.2

14.1

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

803

0.84

0.69

1.6

2.7

187.9

177.7

0.37

767

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

181

0.66

0.69

1.2

1.8

—

(3026470) Cobalt [Mass/volume] in Blood

118

0.59

0.67

1.7

2.0

ug/l

1.0

3.3

—

106

(3024891) Influenza virus A+B Ag [Presence] in Specimen

799

1.16

0.67

1.3

1.1

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

0.53

0.66

1.0

1.5

ug/l

9.6

8.4

—

(21494434) Karyotype in Bone marrow

179

0.67

0.66

1.0

1.2

—

(3001556) Androgen free Index in Serum or Plasma

1.59

0.65

1.6

1.2

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

1.57

0.65

2.2

4.4

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

104

1.44

0.62

1.1

1.3

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

188

0.69

0.62

1.2

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

173

1.33

0.61

1.1

nmol/l

0.6

4.5

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

105

0.57

0.61

1.0

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

508

1.18

0.61

4.9

3.2

mg/l

18.0

23.5

1.38

313

(3000899) Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum

0.00

0.60

0.0

1.5

—

2.5

—

(3010937) Rubella virus Ab [Presence] in Serum

0.00

0.60

0.0

1.1

—

(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum

0.00

0.60

0.0

1.5

—

0.7

—

(3042552) Rheumatoid factor [Units/volume] in Pleural fluid

0.00

0.60

0.0

1.0

—

9.1

—

(3007700) Barley IgE Ab [Units/volume] in Serum

0.00

0.60

0.0

1.1

—

1.0

—

(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum

0.00

0.60

0.0

1.5

—

2.0

—

(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum

0.00

0.60

0.0

1.5

—

1.0

—

(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum

0.00

0.60

0.0

1.5

—

2.6

—

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

0.00

0.60

0.0

1.5

—

1.5

—

(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum

0.00

0.60

0.0

1.5

—

1.4

—

(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum

0.00

0.60

0.0

1.5

—

0.7

—

(3006665) Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum

0.00

0.60

0.0

1.5

—

0.6

—

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

0.00

0.60

0.0

1.5

—

1.7

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

746

0.86

0.59

1.8

3.8

u/ml

4831.2

1973.2

0.40

635

(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma

0.00

0.58

0.0

1.0

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

466

1.18

0.56

1.1

iu/ml

34.1

1123.9

0.54

122

(3042631) Mycobacterium sp identified in Specimen

247

1.26

0.56

1.8

2.7

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

265

1.25

0.56

1.3

1.7

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

483

0.83

0.55

1.2

1.3

u/ml

2.6

5.3

1.67

214

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

1.58

0.54

1.0

1.1

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

1.58

0.54

1.0

1.1

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

126

0.63

0.54

1.0

1.4

—

19.6

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

350

1.20

0.52

1.2

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

242

1.24

0.51

1.3

1.7

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

109

1.38

0.51

1.1

1.3

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

179

0.73

0.50

1.3

1.2

—

(3020961) Endomysium IgA Ab [Titer] in Serum

154

1413

1.09

0.49

1.1

titre

53.0

209.6

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

110

0.64

0.48

1.0

1.2

—

(3017817) Protein [Mass] in Urine collected for unspecified duration

209

1.25

0.46

1.7

2.7

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

200

1.25

0.46

1.1

1.0

—

(3029075) Extractable nuclear Ab panel - Serum

0.61

0.45

1.0

—

(3036071) Salmonella sp Ab [Titer] in Serum

119

0.67

0.45

1.0

1.1

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

153

0.72

0.45

1.3

1.2

—

(3034426) Prothrombin time (PT)

121

0.66

0.45

1.1

1.3

—

(4015189)

1.40

0.45

1.6

3.2

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

1.40

0.45

1.1

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

201

1.25

0.45

1.0

1.2

—

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

652

0.87

0.45

1.5

pmol/l

109.3

154.0

0.54

643

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

126

1375

0.91

0.44

2.2

2.9

u/ml

31.4

46.6

0.87

112

1332

(4281824)

253

0.79

0.44

1.1

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

1.40

0.44

1.1

1.3

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

219

0.78

0.43

1.2

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

202

1.24

0.43

1.1

1.0

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

157

1.28

0.43

1.7

2.0

u/field

3.3

2.0

—

(3045424) Erythrocytes [Presence] in Urine

415

1.16

0.42

1.6

1.5

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

276

1.20

0.42

2.0

5.0

u/ml

33.9

80.4

—

(3000285) Sodium [Moles/volume] in Blood

1.56

0.42

1.2

1.0

—

(1617658) Protocol used for examination of sentinel lymph nodes

206

0.78

0.41

1.0

1.1

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

286

1.19

0.41

1.2

1.4

—

(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid

0.00

0.41

0.0

5.8

—

471.7

—

(3024316) Viscosity of Plasma

0.00

0.41

0.0

1.0

—

1.7

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

0.00

0.41

0.0

2.8

—

(3000510) Lepidoglyphus destructor IgE Ab [Units/volume] in Serum

0.00

0.41

0.0

1.1

—

0.2

—

(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose

0.00

0.41

0.0

1.1

—

8.1

—

(3015665) Acarus siro IgE Ab [Units/volume] in Serum

0.00

0.41

0.0

1.0

—

0.1

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

498

0.86

0.41

1.1

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

305

1.18

0.40

1.2

1.5

pmol/l

608.0

308.9

0.83

242

(3042951) Complement C1q Ab [Units/volume] in Serum

0.00

0.40

0.0

1.1

—

23.7

—

(3024263) Appearance of Synovial fluid

114

1.32

0.40

1.1

2.1

—

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

1.47

0.40

3.4

2.0

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

482

5007

0.96

0.40

3.4

3.5

22.5

21.0

1.07

165

2027

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

0.00

0.40

0.0

1.0

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

0.00

0.39

0.0

1.2

—

(3029856) Leukocytes [#/volume] in Peritoneal dialysis fluid

0.00

0.39

0.0

12.4

—

204.2

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

288

1.18

0.39

1.2

1.4

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

494

0.87

0.38

1.2

1.3

u/ml

1.4

4.5

2.91

163

(3005988) Vibrio sp identified in Specimen by Organism specific culture

289

1.18

0.38

1.2

1.4

—

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

113

0.71

0.37

1.0

1.3

—

60.8

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

257

0.82

0.37

2.4

3.1

nmol/l

0.9

0.8

0.08

198

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

116

0.69

0.37

1.0

1.4

—

950.0

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

216

1.21

0.36

1.2

1.3

e6/l

58188.3

65918.2

0.07

155

(3051611) Lipemic interference index of Serum or Plasma

226

1.20

0.35

2.6

3.3

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

269

2824

0.95

0.35

5.3

3.9

29.4

31.4

2.87

216

2020

(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma

126

0.71

0.35

1.2

1.1

iu/ml

426.4

197.7

—

126

(3044927) Protein electrophoresis panel - Urine

189

0.79

0.34

1.3

1.1

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

0.69

0.33

1.2

1.6

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

1.35

0.32

1.1

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

119

1.26

0.31

1.3

1.9

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

119

1.26

0.31

1.3

1.9

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

119

1.26

0.31

1.3

1.9

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

119

1.26

0.31

1.3

1.9

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

1.32

0.30

1.1

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

1.33

0.30

1.0

1.1

—

(3049717) Cytology report of Urine Cyto stain

697

1.09

0.29

2.0

2.5

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

312

0.86

0.28

1.0

1.1

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

128

0.78

0.26

1.3

1.2

—

(3000012) Reticulocyte production index

104

1.25

0.26

2.8

1.6

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

300

1.13

0.26

1.1

1.0

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

195

2042

0.95

0.26

2.6

4.2

ug/l

9.9

19.8

0.95

168

1607

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

234

0.85

0.24

1.1

1.6

umol/l

14.9

11.7

—

224

(3006270) Folate [Moles/volume] in Blood

191

0.84

0.24

1.0

1.1

nmol/l

270.3

393.0

—

181

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

115

1219

0.94

0.24

1.8

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

0.74

0.24

1.0

1.5

—

(4133840)

0.72

0.24

1.3

1.1

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

293

1.13

0.24

1.2

1.4

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

275

0.87

0.23

1.4

1.6

51.5

56.5

0.27

171

(44806071)

1.32

0.23

1.0

—

(4306422)

494

0.91

0.22

1.2

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

257

1.13

0.22

1.1

—

(21494890) Protein electrophoresis panel - 24 hour Urine

191

1.15

0.21

1.4

2.1

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

124

0.81

0.21

1.1

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

172

1648

1.05

0.21

1.2

1.4

—

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

0.00

0.21

0.0

1.8

—

(3025886) Oxalate [Mass/time] in 24 hour Urine

0.00

0.21

0.0

1.0

—

(3013862) HLA-DP [Type]

0.00

0.21

0.0

1.0

—

(46236302) HLA-C [Type] by High resolution typing

0.00

0.21

0.0

1.0

—

(40760410) HLA-B [Type] by High resolution

0.00

0.21

0.0

1.0

—

(40763590) HLA-DQ beta [Type]

0.00

0.21

0.0

1.0

—

(40760409) HLA-A [Type] by High resolution

0.00

0.21

0.0

1.0

—

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

0.00

0.21

0.0

4.0

—

(3034614) HLA Ag [Interpretation]

0.00

0.21

0.0

1.2

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

0.00

0.21

0.0

1.8

—

(3006245) CD3-CD19+ cells/100 cells in Blood

101

0.79

0.21

1.5

2.1

19.1

9.0

—

(3007449) CD3+CD8+ (T8 suppressor) cells/100 cells in Blood

101

0.79

0.21

1.5

2.0

17.5

29.3

—

(3025315) Body weight

0.00

0.21

0.0

3.6

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

0.00

0.21

0.0

5.1

—

(3043410) Blood group antigens tested for on Red Blood Cells

1.25

0.20

2.5

1.3

—

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

0.00

0.20

0.0

1.0

—

(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded

0.00

0.20

0.0

1.0

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

1.22

0.20

1.2

1.3

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

210

2174

0.96

0.19

2.7

2.3

nmol/l

10.6

13.3

5.02

185

1976

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

154

0.84

0.19

1.1

miu/ml

1354.4

1505.6

0.19

154

(40768806) Pleura Pathology biopsy report

156

1.15

0.18

1.4

1.7

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

796

0.94

0.18

1.9

2.8

g/l

3.9

3.6

0.81

751

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

176

1.14

0.17

4.0

1.6

—

(3035880) pH of Pleural fluid

1.22

0.17

1.1

1.4

—

(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay

1.11

0.17

1.0

1.1

130.3

98.8

—

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

1.11

0.17

1.0

1.1

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

340

0.91

0.16

1.1

1.7

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

642

6320

1.02

0.16

3.3

4.0

ug/l

1.5

2.0

3.83

575

5766

(4268621)

329

0.91

0.16

2.2

2.4

—

(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum

216

1.11

0.15

1.1

1.3

—

41.4

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

119

0.84

0.15

1.1

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

624

1.06

0.15

2.9

3.6

u/ml

0.3

0.05

346

(44813793)

207

1.11

0.15

1.1

1.0

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

1.10

0.15

1.0

1.1

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

1.08

0.14

1.0

1.4

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

1.08

0.14

1.0

1.4

—

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

1.18

0.14

1.2

1.1

122.9

109.2

0.58

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

1.18

0.14

1.8

3.0

—

(3035933) Granulocytes/100 leukocytes in Blood

100

0.80

0.13

22.8

1.4

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

105

1090

0.96

0.13

1.6

1.7

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

173

1774

0.97

0.11

1.2

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

146

0.89

0.10

1.4

1.6

u/l

15.8

6.4

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

616

0.96

0.10

1.2

1.4

—

(3051651) Icteric interference index of Serum or Plasma

155

1.10

0.09

2.1

3.6

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

257

0.93

0.08

1.0

1.1

—

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

0.82

0.08

1.2

1.4

86.0

55.0

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

1.14

0.08

1.0

10.2

mg/l

87.4

61.6

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

1.08

0.08

1.0

1.1

—

(3044941) Cell count panel - Synovial fluid

358

0.95

0.08

1.3

1.5

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

421

1.05

0.07

1.4

1.7

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

0.80

0.07

1.3

1.7

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

698

1.03

0.07

2.6

3.1

mg/l

1.5

1.4

0.68

657

(3012441) Differential panel - Pleural fluid

147

1.09

0.07

1.6

1.5

—

(3028433) Virus identified in Specimen by Culture

0.86

0.07

1.3

—

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

0.82

0.07

1.1

2.1

—

32110.6

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.07

0.07

1.0

1.1

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

265

0.94

0.07

1.1

1.2

mg/l

29.6

40.5

1.68

217

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

101

0.89

0.06

1.3

1.2

120.3

107.9

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

229

1.05

0.04

1.2

u/l

71.4

55.9

0.33

156

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

338

1.04

0.04

1.1

1.4

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

289

1.04

0.04

1.2

1.4

—

(3016750) Collection duration of Urine

139

0.93

0.03

2.2

2.6

min

575.6

497.1

—

109

(4027681)

209

0.96

0.03

1.2

—

(3032773) Endomysium IgG Ab [Titer] in Serum

241

1.04

0.02

1.1

—

(3007164) IgA [Mass/volume] in Serum or Plasma

569

5671

1.00

0.02

1.3

1.4

g/l

2.1

2.3

2.39

293

3687

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

319

0.97

0.02

1.2

1.3

nmol/l

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

218

0.96

0.02

1.4

1.5

37.9

35.0

0.13

135

(3025130) Human papilloma virus identified in Specimen

439

0.98

0.02

1.4

1.8

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

117

0.94

0.01

1.9

1.8

—

(3009445) Proteinase 3 Ab [Units/volume] in Serum

103

1039

0.99

0.01

1.1

1.5

u/ml

—

14.3

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

197

1980

0.99

0.01

3.2

2.4

ml/min/173m2

73.6

72.2

0.16

747

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

247

0.97

0.01

1.1

1.4

—

(3000475) Leukocytes [#/volume] in Synovial fluid

543

1.01

0.01

1.3

1.7

e6/l

4704.0

13881.5

3.25

393

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

115

0.96

0.00

1.0

1.1

—

(3013005) Retinol [Moles/volume] in Serum or Plasma

115

1.04

0.00

1.7

umol/l

2.1

2.0

0.14

108

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

1.01

0.00

1.5

2.1

—

(3035320) C reactive protein [Mass/volume] in Body fluid

195

1.03

0.00

2.9

2.2

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

255

0.98

0.00

1.9

2.1

mg/l

10.7

22.6

2.40

(3004451) EKG impression Narrative

104

0.96

0.00

1.0

1.3

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

116

1.03

0.00

1.1

—

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

164

0.98

0.00

1.4

2.4

105.1

98.7

0.48

154

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

1.02

0.00

1.5

2.1

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

1.02

0.00

1.5

2.1

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

102

0.98

0.00

1.0

1.7

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

102

0.98

0.00

1.0

1.7

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

192

0.99

0.00

1.2

1.7

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

393

0.99

0.00

1.1

1.4

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

443

0.99

0.00

1.2

1.6

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

427

1.01

0.00

1.3

1.6

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

0.00

0.0

2.4

—

(3022670) pH of Venous cord blood

0.00

0.0

1.2

—

(3015350) Toxocara sp Ab [Presence] in Serum

0.00

0.0

1.0

—

(3027540) Rickettsia typhi Ab [Titer] in Serum

0.00

0.0

1.2

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

0.98

0.00

1.0

1.1

—

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

0.00

0.0

8.3

—

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

0.00

0.0

1.2

—

(3037377) Propoxyphene + Norpropoxyphene [Presence] in Urine by Confirmatory method

0.00

0.0

1.2

—

(3001409) Leptospira sp IgM Ab [Units/volume] in Serum

0.00

0.0

1.4

—

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

0.00

0.0

1.0

—

(3003593) Leptospira sp IgG Ab [Units/volume] in Serum

0.00

0.0

1.4

—

(3042301) Urate [Moles/volume] in Synovial fluid

0.00

0.0

1.0

—

(3040794) Aluminum [Moles/volume] in Urine

0.00

0.0

1.0

—

(3041184) Isoniazid [Presence] in Urine

0.00

0.0

1.0

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

1.02

0.00

2.8

3.7

—

(3003531) Amoxicillin IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma

0.00

0.0

7.3

—

0.4

—

(40763641) Cell count and Differential panel - Peritoneal dialysis fluid

0.00

0.0

10.0

—

(3046682) IgA [Presence] in Skin by Immunofluorescence

0.00

0.0

1.0

—

(3003157) Bacteria [#/volume] in Mother's milk

0.00

0.0

8.0

—

(3003932) Carbon dioxide [Partial pressure] in Arterial cord blood

0.00

0.0

1.3

—

7.5

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

0.97

0.00

1.0

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

0.97

0.00

1.0

1.1

—

(21493866) Erythrocytes [#/volume] in Peritoneal dialysis fluid by Automated count

0.00

0.0

10.5

—

138.2

—

(3020093) Fractional oxyhemoglobin in Venous cord blood

0.00

0.0

1.3

—

70.8

—

(3027305) Fractional oxyhemoglobin in Arterial cord blood

0.00

0.0

1.3

—

33.6

—

(3002079) Sodium [Moles/time] in 24 hour Urine

0.00

0.0

1.2

—

115.1

—

(3029612) Listeria sp Ab [Titer] in Serum

0.00

0.0

1.1

—

(3017937) Magnesium [Moles/time] in 24 hour Urine

0.00

0.0

1.2

—

(3004282) Tumor necrosis factor.alpha [Mass/volume] in Serum or Plasma

0.00

0.0

3.0

—

7.0

—

(3023693) von Willebrand factor (vWf) multimers in Platelet poor plasma by Immunoblot

0.00

0.0

1.3

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

0.00

0.0

1.0

—

(3013637) Mi-2 Ab [Presence] in Serum

0.97

0.00

1.0

1.1

—

(3006598) pH of Arterial cord blood

0.00

0.0

1.3

—

(3027505) Alpha-1-Fetoprotein [Units/volume] in Amniotic fluid

0.00

0.0

1.0

—

(3007919) Fasciola sp Ab [Titer] in Serum

0.00

0.0

1.0

—

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

0.00

0.0

1.2

—

(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

0.00

0.0

2.0

—

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

0.00

0.0

1.0

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

0.00

0.0

2.0

—

(36303722) Certolizumab [Mass/volume] in Serum or Plasma by Immunoassay

0.00

0.0

1.2

—

27.4

—

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

0.00

0.0

1.0

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

0.00

0.0

1.0

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

0.97

0.00

1.0

1.1

—

(3021706) Oxygen [Partial pressure] in Arterial cord blood

0.00

0.0

1.3

—

2.5

—

(3047185) IgG [Mass/volume] in Urine

0.00

0.0

1.0

—

(3016135) IgD [Mass/volume] in Serum

0.00

0.0

1.3

—

106.5

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

200

1.00

0.00

1.3

1.1

ratio

1.4

1.0

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

0.86

0.00

1.0

1.1

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

0.00

0.0

1.0

—

(3012989) Citrate [Moles/time] in 24 hour Urine

0.00

0.0

1.4

—

2.8

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

560

1.00

0.00

1.4

1.5

nmol/l

0.2

0.4

3.62

446

(3049242) von Willebrand panel - Platelet poor plasma

0.00

0.0

1.8

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

0.00

0.0

2.0

—

(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

0.00

0.0

1.0

—

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

0.00

0.0

1.1

—

(3032333) Phosphate [Mass or Moles] in 24 hour Urine

0.00

0.0

1.9

—

Mortality – FinRegistry

↥

Association

Association between endpoint F5_SCHIZOAFF and mortality.

Females

Parameter	HR [95% CI]	p-value
F5_SCHIZOAFF	3.131 [2.78, 3.53]	< 0.001
Birth year	0.991 [0.98, 1.0]	0.05

During the follow-up period (1.1.1998 — 31.12.2019), 1073 out of 6730 females with F5_SCHIZOAFF died.

Males

Parameter	HR [95% CI]	p-value
F5_SCHIZOAFF	3.091 [2.74, 3.48]	< 0.001
Birth year	0.989 [0.98, 1.0]	0.031

During the follow-up period (1.1.1998 — 31.12.2019), 1030 out of 5175 males with F5_SCHIZOAFF died.

Mortality risk

Mortality risk for people of age

years, who have F5_SCHIZOAFF.

N-year risk	Females	Males
1	0.26%	0.601%
5	1.773%	3.594%
10	3.971%	8.955%
15	7.707%	16.974%
20	13.159%	26.708%

Relationships between endpoints

↥

Index endpoint: F5_SCHIZOAFF – Schizoaffective disorder

GWS hits: 1

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Schizoaffective disorder

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints